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Biomaterial-Associated Infections  
 
Biomaterials play an important role in modern medicine in the restoration of tissue, 
organ or body function. For example, a current estimate of the number of total hip 
replacements in the world amounts approximately one million per year and knee 
replacements more than 250,000. More than 10% of all hospitalized patients are using 
urinary catheters, biomaterial implants or other medical devices. The use of 
biomaterial implants and medical devices is mainly restricted by complications due to 
biomaterial-associated infections (BAI). On average, BAI occurs in approximately 0.5 
– 6% [1,2] of all cases, strongly depending on the implant site, and more often in 
cases of trauma or revision surgery [3-5]. The presence of a biomaterial in the body 
significantly compromises the host to cope with invading microorganisms. There are 
various routes along which microorganisms can enter the body and develop a BAI in 
the case of permanent implants [6]. The best-documented route is direct 
contamination of an implant during surgery (peri-operative contamination). BAI can 
also be initiated immediately post-surgery during hospitalization (post-operative 
contamination) or microbial spreading through blood from infections elsewhere in the 
human body [6-8]. These different routes of infection will be briefly discussed.  
 
Routes of Infection 
 
Peri-operative contamination means that an implant becomes contaminated with 
bacteria before implantation into the human body or during the implantation process. 
During the implantation of a biomaterial implant, microorganisms from the skin can 
reach the implant surface. It is known that during a surgical procedure of 1 h, the total 





bacterial counts are generally higher during periods of activity and when more people 
are present in the operating room [9]. More recent, through the use of modern, better 
ventilated operating theatres (20 changes of air per hour) and impermeable patient and 
personnel clothing, peri-operative bacterial contamination levels may well be less 
[10].  
The second route of infection is post-operative contamination which may 
occur during the period of hospitalization immediately post-surgery, caused by direct 
contamination of open wounds or by the use of invasive devices like infusion tubes, 
drains and catheters. Both peri-operative and post-operative infections can cause BAI 
many years after implantation, because bacteria on a biomaterial implant surface are 
known to be able to stay on the implant in a low metabolic state for several years [6].  
As a third route, BAI can result from hemotogenous spreading of bacteria 
from infections elsewhere in the body, which upon adhering to a biomaterial implant 
surface form a biofilm. This includes skin infections, surgical or dental interventions, 
pneumonia, abscesses or bacteriuria, which can cause temporal or chronic bacteremia 
resulting in BAI [7]. It is also shown that macrophages play a major role in 
transporting bacteria to the implant surface, as some strains are capable to survive 
within macrophages [11,12].  
 
Microbial Adhesion to Biomaterials 
 
The introduction of bacteria by any of the above routes to the biomaterial surface is 
the initial step in the development of BAI. Microorganisms can reach the biomaterial 
surface as early as during implantation and interact with bare substratum surfaces, not 
even covered with a conditioning film, i.e. a film of adsorbed serum or plasma 






proteins [8]. In general, microbial adhesion is mediated by the specific interactions 
between cell surface structures and specific molecular groups on the substratum 
surface, or by non-specific interaction forces, such as Lifshitz-Van der Waals, 
electrostatic charge, acid-base interactions and Brownian motion forces. Irrespective 
of the presence or absence of a conditioning film, the physico-chemical surface 
properties of the biomaterial and microorganisms play an important role in the 
adhesion process. Conditioning films on biomaterial surfaces and on bacterial cell 
surfaces play important roles too by changing the physico-chemical surface 
properties. Most proteins in conditioning films are capable of reducing microbial 
adhesion, but fibronectin and fibrinogen have been shown to promote the adhesion of 
certain Staphylococcus epidermidis and Staphylococcus aureus strains [13]. Microbial 
adhesion mechanisms in post-operative infections or hematogeneous infections are 
unclear. Biomaterial implants are usually not completely integrated with host tissue, 
especially when they consist of metal parts which are not easily colonized by host 
tissue cells. An uncovered metal surface can be a site for microbial colonization. 
Moreover, it is possible that by repeated hinging of orthopedic implants, cell/tissue 
damage can occur, providing adhesive sites for microorganisms [6]. 
Once microorganisms adhere to the biomaterial surface, the second step is the 
subsequent growth of the adhering bacteria, accompanied by production of 
Extracellular Polymeric Substances (EPS), leading to biofilm formation, which 
protects the infecting organisms against host immune system and antibiotic treatment 
[14,15]. Eradication of a biofilm is difficult because the populating bacteria are 
protected from the immune system and antibiotics. Bacteria within biofilms generally 





body fluids [16]. In the majority of cases, the final outcome of a BAI is removal of the 
implant.  
 
Pathogens Causing BAI 
 
In general, S. epidermidis and S. aureus are the most frequently isolated pathogens 
from infected biomaterial surfaces. Additionally isolated organisms include 
Escherichia coli and Pseudomonas aeruginosa [6,15,17]. Almost 50% of infections 
associated with catheters, artificial joints and heart valves are caused by S. 
epidermidis [18]. S. aureus is the cause of around 23% of infections associated with 
prosthetic joints [18]. P. aeruginosa is the causative organism of around 12% of all 
hospital acquired urinary track infections, 10% of bloodstream infections and 7% of 
hip-joint infections [19]. S. epidermidis are the common cause of late infections [18].  
Another factor that plays an important role in the pathogenesis of BAI is the 
bacterial virulence [18]. S. aureus and P. aeruginosa infections usually progress much 
more aggressively than BAI caused by S. epidermidis [18,19]. S. aureus appears more 
frequently in acute infections within 4 weeks after surgery, compared to S. 
epidermidis. S. epidermidis is most commonly implicated in delayed septic loosening 
of total joint prostheses [20] or even in presumed a-septic loosening [21], indicating 
its low virulence with only minor clinical symptoms of infection. Pseudomonas is also 
much more virulent than S. epidermidis, which is ascribed to the more aggressive 
endotoxins in the slime. The low virulence of S. epidermidis strains compared to S. 
aureus or P. aeruginosa is due to the lack of additional genes responsible for 
producing tissue damaging toxins [18,19,22]. In S. epidermidis infections, biofilm 






formation is considered the only virulence factor and therefore infections are usually 
sub-acute or chronic [23-25]. 
 
Mammalian Cell Adhesion to Biomaterials 
 
Mammalian cell adhesion to a biomaterial implant surface is crucial for the successful 
integration of the implant within the host tissue. In vivo, when a biomaterial is 
implanted, it becomes immediately coated with proteins (conditioning film) that are 
adsorbed from the local body fluids. Depending on the body site, the surrounding 
fluid can be saliva, urine, tissue fluid, serum or blood and the conditioning film 
mostly consists of adsorbed proteins. The physico-chemical properties of the 
biomaterial surface (chemical composition, hydrophobicity and surface charge) 
control the nature of the adsorbed protein layer [26,27]. Cell adhesion to adsorbed 
proteins is mediated through integrins and other receptors present within the cell 
membrane. Upon adhesion to the protein film, a cascade of intracellular signaling 
events is triggered. Therefore, controlling protein adsorption on the biomaterial 
surface may be critical to control and direct cell responses to biomaterials. 
Unfortunately, proteins like fibronectin and fibrinogen in conditioning films have 
been shown to promote the adhesion of certain S. epidermidis and S. aureus strains 
[13].  
 
The Race for the Surface 
 
In 1987, the orthopedic surgeon Anthony Gristina coined the term “race for the 
surface” to describe the fate of a biomaterial implant in relation with the development 





race between microbial adhesion and biofilm growth on an implant surface versus 
tissue integration. If the race is won by tissue cells, then the surface is covered by 
tissue and less vulnerable to bacterial colonization. On the other hand, if the race is 
won by bacteria, the implant surface will become colonized by bacteria and tissue cell 
functions are hampered by bacterial virulence factors [6]. Irrespective of the route of 
infection, the fate of biomaterial implants depends mainly on the outcome of the so-
called ‘race for the surface’. 
 
Fig. 1. Schematic diagram representing the race between bacteria and tissue cells for the 
biomaterial surface [6].  
 
Bridging the Gap Between In Vitro and In Vivo Studies 
 
In vivo, processes occurring at the biomaterial site are complex, involving multiple 
cell types depending on the site, cytokines, chemokines, excretion of bacterial and cell 
substances. Normalization of macrophage response on biomaterials allows appropriate 
antibacterial activities, healing and integration. During infection, macrophages play a 
key role in the elimination of bacterial colonization [17].  
In the path towards reducing the risk of BAI, biomaterials research has been 
focused on the development of biomaterials or coatings that can prevent bacterial 
adhesion and stimulate mammalian cell growth. Till today, biomaterials or functional 






coatings were evaluated in vitro either for their ability to resist bacterial adhesion or 
for their ability to support mammalian cell adhesion and proliferation based on the 
concept of the race for the surface [28-33]. Shi et al. [28] showed that a surface 
composed of chitosans and RGD-containing peptides discouraged bacterial adhesion 
but enhanced cell attachment and alkaline phosphatase activity. Dexter et al. [30] 
suggested that an optimal concentration of seeded 3T3 fibroblasts and conditions to 
stimulate cell adhesion without stimulating bacterial adhesion, could probably reduce 
infection. Ploux et al. [33] showed an opposite adhesion behavior of bacteria 
compared to human osteoprogenitor cells on the nano-patterned surfaces prepared by 
pulsed plasma polymerization and UV-irradiation. 
However, none of the above studies have made an attempt to address the 
simultaneous effects of the presence of bacteria and mammalian cells on a biomaterial 
surface, which according to the concept of the ‘race for the biomaterial surface’, is 
crucial for the ultimate fate of a biomaterial implant. The reason for this omission is, 
that hitherto no methodology exists to this end. A proper method to study the race for 
the surface on an experimental basis, would constitute a valuable bridge between in 
vivo and in vitro studies.  
 
Aim of this Thesis 
 
The aim of this thesis is to develop a method that could bridge the gap between in 








Fig. 2. Schematic diagram representing the bridge connecting the gap between traditional in 
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Biomaterials play a major role in modern medicine for the restoration of function, 
frequently used examples being prosthetic joints or heart valves. Biomaterials-
associated infections (BAI) pose a serious complication, which is of growing concern 
due to the increasing use of biomaterial implants and devices. On average, BAI occurs 
in approximately 0.5 – 6% [1,2] of all cases, strongly depending on the implant site, 
and more often in cases of trauma or revision surgery [3-5]. BAI is difficult to treat, as 
the biofilm mode of growth protects the infecting organisms against the host immune 
system and antibiotic treatment [6,7]. In most cases, the final outcome of a BAI is 
removal of the implant. There are various routes along which a BAI can develop. The 
best-documented route is direct contamination of the implant during surgery (peri-
operative contamination) or contamination during hospitalization [8-10]. Since 
microorganisms can remain dormant for several years on a biomaterial surface [9,11] 
inside the human body or in adjacent tissue [9], BAI can become clinically manifest 
years after insertion of an implant. Moreover, late BAI can develop by microbial 
spreading through blood from infections elsewhere in the human body, but evidence 
for haematogenous spreading is mainly anecdotal. 
In 1987, the orthopedic surgeon Anthony G. Gristina coined the term “race for 
the surface” to describe the fate of biomaterial implants in relation with the 
development of BAI [9]. The fate of a biomaterial implant was pictured as a race 
between microbial adhesion and biofilm growth on an implant surface versus tissue 
integration. If the race is won by tissue cells, then the surface is covered by tissue and 
less vulnerable to bacterial colonization. On the other hand, if the race is won by 
bacteria the implant surface will become rapidly covered by a biofilm and tissue cell 
functions are hampered by bacterial virulence factors and toxins. To the aid of the 
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implant, its surface may generate an inflammatory reaction at the tissue interface, 
resulting in the activation of the immune system which may hamper bacterial 
colonization [9,12]. Unfortunately, microorganisms are frequently introduced on an 
implant surface during surgery and in vivo, microorganisms start the race for the 
surface before tissue integration can occur.  
The concept of the race for the surface has been embraced by many 
researchers in the field, but hitherto there has been no in vitro experimental 
methodology forwarded to study the actual race. New biomaterials or functional 
coatings are either evaluated for their ability to resist bacterial adhesion and biofilm 
formation [13-16] or for their ability to support tissue cell adhesion and proliferation 
[13,16-18]. The aim of this study is to describe an in vitro experimental methodology 
to investigate the race for the surface between bacteria and tissue cells in a single 
experiment. 
 
Materials and Methods 
 
U2OS cell culturing and harvesting. U2OS osteosarcoma cells were routinely 
cultured in Dulbecco’s modified Eagle’s Medium (DMEM) -low glucose 
supplemented with 10% fetal calf serum (FBS), 0.2 mM of ascorbic acid-2-phosphate 
(AA2P) denoted in the paper as DMEM+FBS. U2OS cells were maintained at 37°C in 
a humidified 5% CO2 atmosphere, and cells were passaged at 70 – 90% confluency 
using trypsin/EDTA.  
 
Bacterial growth conditions and harvesting. Staphylococcus epidermidis ATCC 
35983, originally isolated from human blood of a patient with an infected 
intravascular catheter, was used throughout this study. First, the strain was streaked on 






a blood agar plate from a frozen stock and grown overnight at 37°C. The plate was 
then kept at 4°C. For each experiment, a colony was inoculated in 10 ml of tryptone 
soy broth (TSB; OXOID, Basingstoke, United Kingdom) and cultured for 24 h. This 
culture was used to inoculate a second culture in TSB, which was grown for 17 h prior 
to harvesting. Bacteria were harvested by centrifugation at 5000 x g for 5 min at 10°C 
and washed twice with sterile ultrapure water. Subsequently, the harvested bacteria 
were sonicated on ice (3 x 10 s) in sterile PBS (10 mM potassium phosphate, 0.15 M 
NaCl, pH 7.0) in order to break bacterial aggregates. This suspension was further 
diluted in sterile PBS to a concentration of 3 x 105 bacteria per ml. 
 
Development of modified culture medium. In order to grow both S. epidermidis and 
U2OS cells simultaneously, a suitable medium had to be developed. To this end, 
bacterial medium (TSB) and tissue growth medium (DMEM+FBS) were combined in 
different ratios and growth rates of both S. epidermidis and U2OS cells were 
determined.  
To determine U2OS cell growth, 1 ml U2OS cell suspension, containing 
600,000 cells, was mixed in combined media with different amounts of TSB and 
seeded into T25 cell culture flasks. After incubation at 37°C in a humidified 5% CO2 
atmosphere for 48 h, cells were detached using trypsin-EDTA solution (Invitrogen, 
Breda, The Netherlands) and counted in a Bürker-Türk counting chamber. During 
incubation, cell adhesion, spreading and morphology were assessed every 24 h using 
phase-contrast light microscopy. 
S. epidermidis ATCC 35983 was inoculated from agar plates in 10 ml of the 
combined media consisting of different amounts of TSB and (DMEM+FBS) for 24 h. 
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This culture was used to inoculate a second culture in combined media, which was 
grown overnight. Bacteria were counted using a Bürker-Türk counting chamber. 
The medium composition showing optimal S. epidermidis and U2OS cell 
growth was chosen for further studies and will be denoted as “modified culture 
medium” in the remainder of this study. 
 
Substratum. For ease of use (optimal transparency), glass was used as a substratum 
surface. Microscope glass slides were cleaned in a 2% RBS 35 detergent solution 
(Omniclean, Breda, The Netherlands) under sonication and thoroughly rinsed in 
demineralized water, methanol, water again and finally washed with sterile ultrapure 
water. This cleansing yielded full spreading of water, immediately after cleaning.  
 
The race for the surface under static conditions. Glass slides were exposed in Petri 
dishes to different concentrations of S. epidermidis ATCC 35983 and incubated at 
37°C for 30 min. Subsequently, the bacterial suspensions were removed by rinsing 
with PBS. Images of adhering bacteria were obtained using a CCD camera (Basler 
AG, Germany) mounted on a phase-contrast microscope (Leica Microsystems Ltd, 
Germany) with a x30 objective and bacterial adhesion was expressed as the number of 
bacteria adhering cm-2. Subsequently, U2OS cells suspended in modified culture 
medium were seeded on bacterial-coated glass plates to a density of 20,000 cells cm-2. 
S. epidermidis and U2OS cells were maintained at 37°C in a humidified 5% CO2 for 
48 h. Images were obtained using Leica DMIL microscope (Leica Microsystems Ltd, 
Germany) at x10 magnification after 48 h and analyzed using Scion image software.  
 
The race for the surface under flow conditions. The parallel plate flow chamber 
and image analysis system have been described in detail previously [19]. The flow 






chamber used was equipped with heating elements and kept at 37°C throughout the 
experiment. Bacterial and cellular deposition were observed with a CCD camera 
(Basler AG, Germany) mounted on a phase-contrast microscope Leica DM2000 
(Leica Microsystems Ltd, Germany) with a x30 objective for bacteria and x10 
objective for tissue cells. 
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, taking care to remove all air bubbles from the system. Once the system 
was filled, and before the addition of the bacterial suspension, PBS was allowed to 
flow through the system at a shear rate of 11 s-1. Then, the bacterial suspension in 
PBS was perfused through the chamber at the same shear rate and images were 
obtained as a function of time. As soon as the desired density of adhering bacteria 
(102 cm-2 or 105 cm-2), was reached, flow was switched to sterile PBS in order to 
remove the bacterial suspension from the tubes and chamber. Subsequently, a U2OS 
cells suspension in modified culture medium was allowed to enter the flow chamber. 
Once the entire volume of buffer inside the chamber was replaced by cell suspension, 
flow was stopped for 1.5 h in order to allow cells to adhere and spread on the 
substratum. Finally, modified culture medium supplemented with 2% HEPES was 
perfused through the system at a low shear rate of 0.14 s-1 for 48 h without 
recirculation, and images were obtained continuously and analyzed real-time.  
After 48 h of medium flow, the samples from the flow chamber were prepared 
for immunocytochemical staining to assess U2OS cell morphology and spreading. For 
fixation, glass slides with S. epidermidis and U2OS cells were placed in a Petri dish 
with 30 ml of 3.7% formaldehyde in cytoskeleton stabilization buffer (CS; 0.1 M 
Pipes, 1 mM EGTA, 4% (w/v) polyethylene glycol 8000, pH 6.9). After 5 min, the 
fixation solution was replaced by 30 ml of fresh CS for another 5 min. Subsequently 
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cells were incubated in 0.5% Triton X-100 for 3 min, rinsed with PBS and stained for 
30 min with 5 ml PBS containing 49 µl DAPI and 2 µg ml-1 of TRITC-Phalloidin. 
The cells on the glass slide were washed 4 times in PBS and examined with confocal 
laser scanning microscopy (Leica DMRXE with confocal TCS SP2 unit). The number 
of adhering cells per unit area and the average area per spread cell were determined 
using Scion image software. For each density of adhering bacteria, 6 images (900 x 
700 µm) per sample were randomly chosen and analyzed.  
In order to assess the viability of U2OS cells adhering to the glass slide after 
48 h of flow, vitality staining solution (2 µM calcein-AM and 3.4 µM ethidium 
homodimer-1 (Molecular Probes Inc.) in PBS) was directly added to the adhering 
U2OS cells, after which slides were left for 15 min in the dark at room temperature 
with a coverslip on top.  
 
Statistics. Experiments for each density of adhering bacteria both under static and 
flow conditions were carried out in triplicate. Data are represented as a mean with 
standard deviation. Statistical ANOVA analysis was performed, followed by a Tukey 




Development of a modified culture medium. U2OS cells were cultured in different 
ratios of DMEM+FBS and TSB media, but did not show any growth in media 
containing more than 30% TSB (see Fig. 1). No changes in cell morphology were 
observed, when U2OS cells were cultured in media containing 2% and 4% TSB 
compared to cells grown in 100% DMEM+FBS. For higher percentages of TSB, 
change in U2OS cell morphology and subsequent cell death were observed. 






Analogously, the growth of S. epidermidis ATCC 35983 dropped considerably when 
the TSB content was less than 20% and close to zero in 100% DMEM+FBS medium 
(see also Fig. 1). From the above results, while considering U2OS cell morphology as 
the most important factor, it was decided to employ a modified medium consisting of 
98% DMEM+FBS and 2% TSB for further experiments. In this modified growth 
medium U2OS cells had an advantage in growth over the bacteria, but both showed 
significant growth (see also Fig.1).  
 
Fig. 1. Growth of U2OS cells (■) and S. epidermidis ATCC 35983 (♦) as a function of the 
percentage of DMEM+FBS in combination with TSB medium. Horizontal lines indicate the 
number of U2OS cells (dash-dotted) and bacteria (dotted) prior to growth. Growth was 
registered after 48 h.  
 
Adhesion of U2OS cells in the presence of S. epidermidis - static versus flow 
conditions. The response of U2OS cells to the presence of adhering staphylococci 
under static conditions versus low fluid flow is shown in Fig. 2. In the absence of 
staphylococcal adhesion, slightly more (p<0.05) U2OS cells adhere after 48 h under 
static conditions than under flow. Under static conditions and in the presence of 
adhering staphylococci however, U2OS cell adhesion was greatly reduced as 
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compared to the control, i.e. in the absence of adhering bacteria (p<0.05). Under 
medium flow conditions, the number of adhering U2OS cells was significantly 
reduced for both staphylococcal concentrations as compared to the control (p<0.05).  
 
Fig. 2. Number of U2OS cells seeded on a glass substratum after 48 h under static conditions 
(■) and under medium flow (□) and in the absence and presence of adhering S. epidermidis 
ATCC 35983. Error bars represent the standard deviation over three replicates, with separate 
bacterial and cell cultures. *,° Significantly different (p<0.05) from the control (absence of 
staphylococci).  
 
Under static conditions and irrespective of the number of S. epidermidis initially 
present, floating granular particles were observed and interpreted as cell debris, 
indicating U2OS cell death. In the presence of S. epidermidis, U2OS cells showed 
better spreading and survival rate under flow as compared to static conditions. This is 
due to the continuous flow, which likely removes the majority of bacterial endotoxins 
produced. Bacterial endotoxin-induced cell death was confirmed by culturing U2OS 
cells in growth medium consisting of 50% fresh modified growth medium and 50% 
supernatant from a 48 h mixed U2OS cell and bacterial culture. No growth and 
subsequent U2OS cell death was observed in this mix of fresh and spent medium, 






confirming that bacterial endotoxins are responsible for cell death during the race for 
the surface under static conditions. Fluorescent dead-live stain, comprising of calcein- 
AM and ethidium homodimer-1, also confirmed that adhering U2OS cells were alive 
in the presence of S. epidermidis after 48 h under flow, as shown in Fig. 3. 
 
Fig. 3. CSLM live-dead images of U2OS cells after 48 h on glass under medium flow in the 
absence and presence of adhering staphylococci. Bar denotes 75 µm.  
 
Influence of the number of adhering S. epidermidis on adhesion and spreading of 
U2OS cells under medium flow. Adhesion and spreading of U2OS cells after 1.5 and 
48 h of growth in the presence of different number of adhering S. epidermidis are 
shown in Fig. 4. After 48 h the number of adhering bacteria had also increased due to 
growth, which made it difficult to analyze the cell number and spreading. For this 
reason, the adhering U2OS cells were stained and analyzed by CLSM (see Fig. 5). 
 
Fig. 4. U2OS cells adhesion and spreading after 1.5 h (top series) and 48 h (bottom series) 
under medium flow on a glass substratum in the absence and presence of adhering 
staphylococci. Bar denotes 75 µm. U2OS cells are differentiated by a contour line from S. 
epidermidis biofilm.  
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U2OS cells showed highest spreading in the absence of staphylococci. The 
extent of spreading was reduced with increasing density of adhering staphylococci 
and in the presence of adhering staphylococci many non-spread U2OS cells were 
observed. Quantitative analysis of cell spreading in the absence and presence of 
staphylococci is shown in Fig. 6. After the initial adhesion of U2OS cells for 1.5 h, 
the average area of U2OS cells on all surfaces was between 250 µm2 and 380 µm2 per 
cell. After 48 h of flow, significant differences were observed in the average area per 
cell as a result of varying densities of adhering S. epidermidis. In the absence of S. 
epidermidis, the average area of a spread cell was 960 µm2 after 48 h, but in the 




Fig. 5. CLSM images of U2OS cells after 48 h on glass under medium flow in the absence 
and presence of adhering staphylococci. U2OS cells were stained with 5 ml PBS containing 
49 µl DAPI and 2µg ml-1 of TRITC-Phalloidin. Bar denotes 75 µm.  







Fig. 6. Average area per spread U2OS cell after 1.5 h (□) and 48 h (■) of growth on glass 
under medium flow in the absence and presence of adhering S. epidermidis ATCC 35983. 
Error bars represent the standard deviation over three replicates with separate bacterial and 




This paper presents the first experimental set-up to study the race between bacteria 
and tissue cells for a biomaterial surface in vitro. The need for such a system is 
enormous at current, as many coatings that are propagated to attract low numbers of 
adhering bacteria, such as polymer brush coatings [15,20], may also be expected to 
support poor adhesion and spreading of tissue cells, which is currently stimulating the 
development of bi-functional coatings that support cell spreading and repel 
microorganisms at the same time. This development necessitates the use of a 
methodology, as described in this manuscript. Under static culturing conditions, 
U2OS cells did not have a chance to win the race for the surface and detached from 
the surface in the presence of adhering staphylococci. Under medium flow, however, 
U2OS cells remained adhering in the presence of adhering staphylococci and spread 
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more when the density of adhering staphylococci was lower. Therewith we have 
presented a method for the evaluation of biomaterial coatings that encompasses tissue 
cell adhesion and spreading as well as bacterial growth. 
The effects of two different densities of adhering bacteria were evaluated in 
this study. Bacteria were allowed to adhere prior to cell adhesion and spreading, 
which is a fine-tuning of the model toward peri-operative bacterial contamination of 
implant surfaces. It has been documented that during an operation procedure of 1 h 
[21], the total number of bacteria-carrying particles falling on a wound is about 270 
cm-2, while the risk of infection depends on the number of viable bacteria present in 
the wound area at the time of wound closure. Bacterial counts are generally higher 
during periods of activity or during increased numbers of personnel in the operation 
theatre [21]. The presence of a biomaterial implant in the body usually stimulates 
infection by a smaller inoculum of bacteria than in non-biomaterial surgery [22]. 
Hence, the densities of adhering bacteria prior to cell adhesion employed in this study 
between 102 and 105 bacteria cm-2 may be considered relevant for minimum and 
maximum contaminations occurring clinically. 
U2OS cell response was studied under static conditions and flow. In vivo, fluid 
is continuously flowing through the network of fine channels of osteocytes to 
facilitate the diffusion of nutrients and waste products from the bone surface to deeply 
buried osteocytes and vice versa [23]. Using computer simulation, Klein-Nulend and 
co-workers [24] showed that flow rates are low in the region of bone immediately 
ahead of the basic multicellular units. They also showed that cells die in this stagnant 
area, possibly because of lack of nutrients. Similarly in our study under static 
conditions, cell death was observed irrespective of different densities of adhering 
bacteria. Under flow, detachment of cells was not observed and cells were alive due to 






the continuous incoming of fresh medium and removal of endotoxins. Hence, 
conducting the race for a biomaterial surface between bacteria and tissue cells in vitro 
under low flow may be considered clinically relevant, although exact flow rates as 
occurring in vivo are unknown. 
Several researchers predict the outcome of the race for the surface by studying 
the bacteria-surface interactions and tissue cell-surface interactions separately, but this 
is not how we interpret Gristina’s meaning of “the race for the surface”, neither do we 
think this is the right way to study the possible fate of a biomaterial implant in vitro. 
Many biomaterial coatings have been identified as non-adhesiveness to bacteria or 
support tissue integration separately [6,13-15,17,18], but the combination of both 
bacteria and tissue cells on the same biomaterials surface has never been studied. Shi 
et al. [16] for instance, promoted a surface composed of chitosans and Arginine-
Glycine-Aspartic acid (RGD) peptide sequences. In separate experiments, it was 
shown that these combined surfaces discouraged bacterial adhesion, and enhanced cell 
attachment and Alkaline Phosphatase (ALP) activity. However, effects of bacterial 
presence, including the influence of bacterial activities and toxins [12] on the tissue 
cell attachment were not studied, which could completely change the fate of a 
biomaterial implant according to the concept of “race for the biomaterial surface”. 
The methodology forwarded here allows simultaneous growth of bacteria and tissue 
cells on the same biomaterial surface and will be useful for the evaluation of new 




A novel in vitro methodology to study the race between bacteria and tissue cells for a 
biomaterial surface has been developed. Although due to the cell type chosen and use 
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of a staphylococcal strain, the methodology as described here may seem geared 
toward orthopedic applications, we emphasize that its principles are equally 
applicable to other implant systems, such as surgical meshes, or vascular grafts. Both 
the absence and presence of flow, as well as the number of adhering bacteria appeared 
to determine whether tissue cells were able to grow on a biomaterial surface. The 
methodology forwarded is expected to become indispensable for in vitro evaluation of 
bi-functionalized, biomimetic biomaterial coatings currently being developed in 
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Biomaterial implants are indispensable in human function restoration after damage to 
the human body beyond natural repair. The number one cause of failure of biomaterial 
implants is infection, partly as a cause of unsuccessful tissue integration. 
Microorganisms involved in biomaterial-associated infection (BAI) are resistant to 
antibiotics due to their biofilm mode of growth, and infected implants often have to be 
removed before the infection can be fully eradicated from surrounding tissue and a 
new implant can be inserted. On average, BAI occurs in approximately 0.5 – 6% of all 
primary implant patients [1]. BAI has an at least two- to three-fold higher incidence in 
revision surgery. Primary implants can become contaminated with microorganisms 
during implant surgery (peri-operative contamination) or hospitalization [2], as the 
onset of BAI. Whether or not microbial contamination eventually results in BAI, 
depends on the outcome of the so-called ‘race for the surface’ between successful 
tissue integration of the biomaterial implant and biofilm growth [2]. If this race is won 
by tissue cells, then the biomaterial surface is covered by a cellular layer and less 
vulnerable to biofilm formation. On the other hand, if the race is won by bacteria, the 
implant surface will become colonized by bacteria and tissue cell functions are 
hampered by bacterial virulence factors and toxins [2,3]. Since microorganisms are 
frequently introduced on an implant surface during surgery, microorganisms have a 
head start in this race for the surface.  
A better understanding of the combined interaction of tissue cells and bacteria 
on biomaterial surfaces is required in order to develop new biomaterials or functional 
coatings that resist bacterial adhesion and biofilm formation [4-8] and simultaneously  
support tissue cell adhesion and proliferation [5-9]. Since the development of 
biomaterials and functional coatings, bacterial adhesion and biofilm formation are 
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studied independently from tissue cell adhesion and proliferation, and the combined 
outcome of these two interactions, i.e. the race for the surface, remains unknown. 
Recently, an in vitro experimental methodology to investigate the race between 
bacteria and tissue cells in a single experiment has been forwarded [10]. The outcome 
of the race for the surface between staphylococci and tissue cells appeared dependent 
on the number of bacteria present prior to cell seeding and the absence or presence of 
fluid flow. Cells lost the race for the surface in the absence of flow due to 
accumulation of bacterial endotoxins, but were able to grow in the presence of flow 
due to continuous incoming of fresh medium and removal of endotoxins by the flow 
[10].  
Many biomaterials that are often used in the clinic have not yet been 
investigated with respect to the influence of their surface properties on the outcome of 
the race for the surface between bacteria and tissue cells. Surface wettability is one of 
the important properties influencing bacterial or cellular interactions with 
biomaterials. Gottenbos et al. [11]. showed relatively similar bacterial adhesion 
between materials with different wettabilities. Schakenraad et al. [12]. reported that 
tissue cells spread best on wettable and poorly on less wettable surfaces. Therefore the 
aim of this paper is to determine the influence of wettability on the outcome of the 
race for the surface on different biomaterial surfaces. In addition, a surface coated 
with a hydrophilic polymer-brush is included, since these have been shown to 
discourage microbial adhesion and biofilm formation [13]. 
 
Materials and Methods 
 
Biomaterial surfaces. Polyethylene (PE) (Goodfellow, Cambridge, UK), 
Poly(tetrafluoroethylene-co-hexafluoropropylene) (FEP) (Fluorplast, Raamsdonkveer, 






The Netherlands), poly (methyl methacrylate) (PMMA) (Vink Kunststoffen, Didam, 
The Netherlands), Polystyrene (PS) (Colltec, Groningen, The Netherlands), High-
Throughput microArraying, multifunctional slide (HTA) (Greiner Bio One, Alphen 
aan den Rijn, The Netherlands) and glass coated with a hydrophilic polyethylene 
oxide (PEO) layer were used. All samples except hydrophilic PEO-coating were 
rinsed thoroughly with ethanol (Merck, Darmstadt, Germany) and washed with sterile 
ultrapure water before use.  
Hydrophilic PEO-coated glass (polymer-brush coating) was prepared by first 
cleaning microscope glass slides in a 2% RBS35 detergent solution (Omniclean, 
Breda, The Netherlands) under sonication and thorough rinsing in demineralized 
water, methanol, water again and finally washed with sterile ultrapure water. Glass 
surfaces were made hydrophobic by application of a dimethyldichlorosilane coating 
(DDS, Merck, Germany), yielding a water contact angle of 107 ± 2 degrees. Exposure 
to a solution of 0.5 g l-1 Pluronic F-127 solution (PEO99PPO65PEO99, molecular 
weight 12600; Sigma-Aldrich, USA) in phosphate buffered saline (PBS: 10 mM 
potassium phosphate, 0.15 M NaCl, pH 7.0) for 20 min created a hydrophilic 
polymer-brush coating, that has appeared stable and effective against bacterial 
adhesion for at least 48 h [13]. 
 
Biomaterial surface characterization. The wettability of the surfaces was 
determined by water contact angle measurements at room temperature with an image 
analyzing system, using the sessile drop technique. Each value was obtained by 
averaging five droplets on one sample.  
The elemental surface composition of the biomaterial surfaces was measured 
using X-ray Photoelectron Spectroscopy (XPS). The S-probe spectrometer (Surface 
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Science Instruments. Mountain View, CA, USA) was equipped with an aluminium 
anode (10 kV, 22 mA) and a quartz monochromator. The direction of photoelectron 
collection angle was 55 degrees with the sample surface and the electron flood gun 
was set at 10 eV. Broad spectrum survey scans (binding energy range of 1 to 1100 
eV) were made at low resolution (pass energy, 150 eV). The area under each peak was 
used to calculate peak intensities, yielding elemental surface concentrations for 
carbon, oxygen, nitrogen, fluorine and silicon, after correction with sensitivity factors 
provided by the manufacturer. Elemental surface compositions were expressed in 
atom percentages of carbon, oxygen, silicon, fluorine and/or nitrogen. Two separate 
measurements were taken on different spots of each biomaterial. 
 
U2OS cell culturing and harvesting. U2OS osteosarcoma cells were routinely 
cultured in Dulbecco’s modified Eagle’s Medium (DMEM) -low glucose 
supplemented with 10% fetal calf serum (FBS), 0.2 mM of ascorbic acid-2-phosphate 
(AA2P) and denoted in the paper as DMEM+FBS. U2OS cells were maintained at 
37°C in a humidified 5% CO2 atmosphere, and cells were passaged at 70 – 90% 
confluency using trypsin/EDTA.  
 
Bacterial growth conditions and harvesting. Staphylococcus epidermidis ATCC 
35983, originally isolated from human blood of a patient with an infected 
intravascular catheter, was used throughout this study. First, the strain was streaked on 
a blood agar plate from a frozen stock and grown overnight at 37°C. The plate was 
then kept at 4°C. For each experiment, a colony was inoculated in 10 ml of tryptone 
soy broth (TSB; OXOID, Basingstoke, United Kingdom) and cultured for 24 h. This 
culture was used to inoculate a second culture in TSB, which was grown for 17 h prior 






to harvesting. Bacteria were harvested by centrifugation at 5000 x g for 5 min at 10°C 
and washed twice with sterile ultrapure water. Subsequently, the harvested bacteria 
were sonicated on ice (3 x 10 s) in sterile PBS (10 mM potassium phosphate, 0.15 M 
NaCl, pH 7.0) in order to break bacterial aggregates. This suspension was further 
diluted in sterile PBS to a concentration of 3 x 106 bacteria per ml. 
 
The race for the surface. The race for the surface was studied on the bottom plate of 
a parallel plate flow chamber (175 x 17 x 0.75 mm3) prepared from the biomaterials 
or coating under investigation, as described in detail before [10]. The flow chamber 
was equipped with heating elements and kept at 37°C throughout the experiments. 
Bacterial and U2OS deposition were observed with a CCD camera (Basler AG, 
Germany) mounted on a phase-contrast microscope Leica DM2000 (Leica 
Microsystems Ltd, Germany) with a 30x objective for bacteria and 10x objective for 
tissue cells. 
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, taking care to remove all air bubbles from the system. Once the system 
was filled, and before the addition of the bacterial suspension, PBS was allowed to 
flow through the system at a shear rate of 11 s-1. Then, the bacterial suspension in 
PBS was perfused through the chamber at the same shear rate and phase-contrast 
images were obtained and image-analyzed as a function of time. As soon as the 
desired density of adhering bacteria (103 cm-2 or 105 cm-2), was reached, flow was 
switched to sterile PBS to remove the bacterial suspension from the tubes and 
chamber. Subsequently, a U2OS cell suspension in modified culture medium, 
consisting of 98% DMEM+FBS and 2% TSB and suitable for the simultaneous 
growth of U2OS cells and S. epidermidis [10], was allowed to enter the flow chamber. 
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Once the entire volume of buffer inside the chamber was replaced by the cell 
suspension, flow was stopped for 1.5 h in order to allow tissue cells to adhere and 
spread on the substratum. Subsequently, phase contrast images (6 images, 900 x 700 
µm each) were taken and the number of adhering cells per unit area and area per 
spread cell were determined using Scion image software. Finally, modified culture 
medium supplemented with 2% HEPES was perfused through the system at a low 
shear rate of 0.14 s-1 for 48 h without recirculation, and phase-contrast images were 
obtained continuously.  
 
Immuno-cytochemical staining. After 48 h of flow, the biomaterial surfaces or 
coating were prepared for immuno-cytochemical staining to assess the tissue cell 
morphology and spreading. For fixation, surfaces with adhering bacteria and tissue 
cells were placed in a Petri dish with 30 ml of 3.7% formaldehyde in cytoskeleton 
stabilization buffer (CS; 0.1 M Pipes, 1 mM EGTA, 4% (w/v) polyethylene glycol 
8000, pH 6.9). After 5 min, the fixation solution was replaced by 30 ml of fresh CS 
for another 5 min. Subsequently tissue cells were incubated in 0.5% Triton X-100 for 
3 min, rinsed with PBS and stained for 30 min with 5 ml PBS containing 49 µl DAPI 
and 2 µg ml-1 of TRITC-Phalloidin. The cells on the surfaces were washed 4 times in 
PBS and examined with confocal laser scanning microscopy (CLSM, Leica DMRXE 
with confocal TCS SP2 unit). The number of adhering tissue cells per unit area and 
the average area per spread cell were determined using Scion image software. For 
each density of adhering bacteria, 6 images (900 x 700 µm) per sample were 
randomly chosen and analyzed.  
 






Statistics. Experiments for each density of adhering bacteria on different surfaces 
were carried out in triplicate. Data are represented as a mean with standard deviation. 
Statistical ANOVA analysis was performed followed by a Tukey’s HSD post-hoc test 




Biomaterials wettability and surface composition. The water contact angles and 
elemental surface compositions of the biomaterials and polymer-brush coating 
evaluated are summarized in Table 1. The biomaterial surfaces extend over a 
wettability range from 36 to 103 degrees, and are composed for the major part of 
carbon and oxygen, with the exception of FEP, containing fluorine and HTA, 
containing nitrogen. The polymer-brush coating has a wettability of 41 degrees, and 
shows some silicon, originating from the glass underneath the thin polymer-brushes 
consisting of carbon and oxygen.  
 
Table 1. Water contact angle and elemental surface compositions of biomaterials and PEO-





%C %O %F %N %Si 
HTA 36 ± 3 80.1 ± 2.0 16.9 ± 0.6 - 3.1 ± 
1.2 
- 
PMMA 73 ± 3 73.2 ± 0.2 25.9 ± 1.4 - - - 
PS 80 ± 2 94.8 ± 2.2 5.2 ± 2.2 - - - 
PE 95 ± 2 97.2 ± 1.2 2.8 ± 1.2 - - - 





41 ± 5  59.5 ± 0.8 33.6 ± 0.3 - - 6.9 ± 
0.9 
1) data taken from Roosjen et al. [14]. 
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U2OS cell adhesion and spreading in the absence and presence of adhering S. 
epidermidis. Immediately after seeding, U2OS cell adhesion and spreading was 
observed in the absence and presence of adhering staphylococci on all biomaterial 
surfaces evaluated, but not on the polymer-brush coating. At 1.5 h, there was no 
significant difference between the number of adhering U2OS cells on the biomaterials 
(25000 cells cm-2 on average), with the exception of FEP where far less adhering 
tissue cells were found (approximately 12000 cells cm-2). On the polymer-brush 
coating, however, the number of U2OS cells on the surface was 25000 cells cm-2 on 
average at 1.5 h, but these tissue cells adhered loosely and were removed at the 
applied shear rate of 0.14 s-1. Phase-contrast images of U2OS cell adhesion, spreading 
and simultaneous biofilm formation of S. epidermidis after 24 h of growth on the 
biomaterials evaluated and the polymer-brush coatings are shown in Fig. 1. On the 
biomaterials, adhering staphylococci had grown into a biofilm, whereas at the same 
time U2OS cell adhesion and spreading were observed. On the polymer-brush 
coating, the adhering U2OS cells that could withstand the applied shear, did not 
spread and remained rounded even after 24 h (see Fig. 1).  







Fig. 1. U2OS cell spreading and staphylococcal biofilm formation (initial number of 
staphylococci present is 103 cm-2) after 24 h of growth on biomaterials evaluated (HTA = 
High-Throughput microArraying, multifunctional slide, PMMA = Poly (methyl 
methacrylate), PS = Polystyrene, PE = Polyethylene, FEP = Poly (tetrafluoroethylene-co-
hexafluoropropylene)) and a polymer-brush coating. Bar denotes 10 µm.  
 
After 48 h of growth, the number of adhering bacteria had increased to the 
extent that it impeded quantification of cellular adhesion and spreading and hence 
adhering U2OS cells were immunocyto-stained for CLSM analysis (see Fig. 2) to 
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derive the number and spread area of U2OS cells in the absence and presence of 
staphylococci. In Fig. 3 it can be seen, that the % increase in number of adhering 
U2OS cells was significantly reduced due to the presence of adhering staphylococci 
on all biomaterials surfaces as compared to the control, i.e. in the absence of adhering 
bacteria (p<0.05). The number of adhering U2OS cells on hydrophobic FEP showed a 
significant reduction (p<0.01) in % increase with respect to the initial number of S. 
epidermidis present.  
 
 
Fig. 2. CLSM images of immunocyto-stained U2OS cells after 48 h of growth on the 
biomaterials evaluated (HTA = High-Throughput microArraying, multifunctional slide, 
PMMA = Poly (methyl methacrylate), PS = Polystyrene, PE = Polyethylene, FEP = Poly 
(tetrafluoroethylene-co-hexafluoropropylene)) and a polymer-brush coating in the absence (no 
staphylococci) and presence of adhering staphylococci (initial number of adhering 
staphylococci amounted either 103 cm-2 or 105 cm-2). Bar denotes 75 µm. 







Fig. 3. Percentage increase in the number of adhering U2OS cells after 48 h of growth with 
respect to their initial adhesion at 1.5 h as a function of the water contact angles of the 
biomaterials evaluated in the absence (●) and presence (■ – 103 cm-2, ▲ – 105 cm-2) of 
adhering S. epidermidis ATCC 35983. Error bars represent the standard deviation over three 
replicates, with separately cultured bacteria and tissue cells.  
 
U2OS cells showed maximum spreading in the absence of staphylococci on all 
biomaterials evaluated irrespective of their wettabilities, as compared to the presence 
of staphylococci. U2OS cells spread best on hydrophilic surfaces (HTA and PMMA) 
and showed the least spreading on the hydrophobic FEP surface. It is interesting to see 
that the adhering tissue cells, spread equally well in the presence of staphylococci as 
in their absence (see Fig. 4). Note that the total surface coverage of the U2OS cells is 
different in the presence of staphylococci, which is caused by a lower number of the 
adhering bacteria (see Fig. 2). Tissue cell spreading only appeared hampered due to 
the presence of adhering staphylococci on the most hydrophobic surface, FEP. On the 
polymer-brush coating, no increase in the number of adhering U2OS cells was 
observed, neither did the adhering cells spread within 48 h, irrespective of the absence 
or presence of staphylococci. 
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Fig. 4. Average area per spread U2OS cell after 48 h of growth as a function of the water 
contact angles of the biomaterial evaluated in the absence (●) and presence (■ – 103 cm-2, ▲ – 
105 cm-2) of adhering S. epidermidis ATCC 35983. Error bars represent the standard deviation 




This paper presents the first experimental study on the race between bacteria and 
tissue cells on biomaterials with different wettabilities as well as on polymer – brush 
coated glass. Two different densities of bacteria (103 and 105 bacteria cm-2) were 
allowed to adhere prior to cell seeding, adhesion and spreading, which mimicks a 
situation of peri-operative bacterial contamination of implant surfaces. In the past, it 
has been documented that during a surgical procedure of 1 h, the total number of 
bacteria carrying particles falling on the wound is approximately 270 per cm2. The 
bacterial counts are generally higher during the periods of activity and correlate 
positively with the number of personnel present in the operation theatre [15]. In more 
recent, conventionally ventilated operation theatre (20 changes of air per hour) and the 
use of impermeable patient and personnel clothing [16], bacterial contamination will 
be far less, which makes, the bacterial adhesion densities chosen in our experiments a 
worst case scenario.  






Amongst other material properties, surface wettability plays a major role in 
bacterial or cellular interaction with biomaterials. Wettability of biomaterial surfaces 
has been related to bacterial adhesion, cell adhesion and spreading. Gottenbos et al. 
[11]. showed that adhesion of staphylococci is relatively similar on different 
biomaterials, such as PMMA, PE and FEP, irrespective of differences in wettability. 
Likewise, these biomaterials in our study showed similar biofilm formation 
irrespective of their differences in wettability. The adhesion of staphylococci on the 
polymer – brush coating was slow and not as strong as on the biomaterials evaluated. 
A recent study by Nejadnik et al. [13]. showed that the polymer – brush coatings 
reduced adhesion of staphylococci considerably but the few adhered bacteria still 
formed a biofilm when allowed to grow. This biofilm formed on the polymer – brush 
coating detached when exposed to high fluid shear [13]. 
In case of tissue cells, many papers [12,17-19] have suggested that optimal 
tissue cell adhesion and spreading occurs at intermediate wettability (water contact 
angle between 60 degrees and 80 degrees). Nevertheless, surfaces that are poorly 
wettable still support appreciable cell adhesion [12]. Similarly, on the biomaterials, in 
the absence of staphylococci, U2OS cells showed the best adhesion on hydrophilic 
HTA and PMMA and appreciable cell adhesion on hydrophobic FEP (see Fig. 3). The 
percentage adhesion of tissue cells with respect to surface wettabilities of biomaterials 
followed the same trend as demonstrated earlier [20-23]. It is surprising that the 
poorly wettable polymer PE was capable of supporting significant cell attachment and 
spreading. This was also reported by Lydon et al. [23]. in the previous study. U2OS 
cells showed no adhesion and spreading on a polymer – brush coating. 
A combined bacterial and tissue cell adhesion and growth study on biomaterial 
surfaces is novel. This study showed that in the presence of staphylococci, U2OS cell 
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adhesion in terms of numbers of adhering cells, reduced significantly on all 
biomaterial surfaces evaluated, as compared to a control, i.e. in the absence of 
adhering bacteria (p<0.05). Spreading of adhering tissue cells was less affected by the 
presence of bacteria except on hydrophobic FEP. This demonstrates that tissue cell 
interactions with biomaterials are hampered by bacterial presence on all biomaterials, 
establishing a tight race between bacteria and tissue cells for the biomaterial surface. 
Clinically, this is the reason why antibiotics need to be used in order to substantially 
reduce the risk of post-operative infection or BAI [24]. The polymer – brush coating 
showed both reduced bacterial adhesion and tissue cell adhesion and spreading, which 
makes it unsuitable for implant coatings, albeit for a different reason than valid for the 
biomaterial surfaces evaluated. Therefore, this study emphasizes the need for the 
development of bi-functional surfaces, discouraging bacterial adhesion and growth 




This study demonstrates that tissue cell interactions with biomaterials were hampered 
by biofilm formation on biomaterial surfaces and in fact most on a hydrophobic FEP 
surface. This indicates that the race for the biomaterial surface a tight one, as can be 
inferred from the relatively high rate of occurrence of BAI. As such, neither 
hydrophobic nor hydrophilic surfaces aid in a decisive way to determine the outcome 
of the race for the surface. Polymer-brush coatings appear less promising in 
determining the race for the surface than expected on the reductions observed in 
bacterial adhesion and growth on polymer-brush coatings, because they do not 
support tissue cell adhesion and spreading. Surfaces, on which the race for the surface 
can be won with certainty by the tissue cells, do not yet exist. Biomaterials 






engineering should aim for bi-functional surfaces, discouraging bacterial adhesion and 
growth, but at the same time supporting tissue adhesion and spreading. Hitherto, these 
two requirements have not been met by any of the biomaterials surfaces currently 
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Biomaterial-associated infection (BAI) is a serious problem in modern medicine. BAI 
is often difficult to treat, as the biofilm mode of growth protects the infecting 
organisms against the host defense system and antibiotics [1]. In most cases, the final 
outcome is removal of the infected implant. Biomaterial implants can become 
contaminated in different ways. The best documented route is direct contamination of 
the implant surface during surgery (peri-operative contamination) or contamination 
during hospitalization. Whether or not microbial contamination eventually results in 
BAI, depends on the outcome of the so-called ‘race for the surface’ between 
successful tissue integration of the implant surface and biofilm formation [2]. If this 
race is won by tissue cells, then the implant surface is covered by a cellular layer and 
less vulnerable to biofilm formation. On the other hand, if the race is won by bacteria, 
the implant surface will become colonized by bacteria and tissue cell functions are 
hampered by bacterial virulence factors and toxins [2,3]. Since microorganisms are 
frequently introduced on an implant surface during surgery, microorganisms have a 
head start in this race for the surface. In the concept of the race for the surface, full 
coverage of an implant surface in vivo by a viable tissue cell layer, intact cell 
membrane and functional host defense mechanisms resist biofilm formation [4]. 
Previously, we proposed an in vitro model to experimentally determine the 
influence of peri-operative bacterial contamination on the race for the surface, in 
which adhesion, spreading and growth of mammalian cells on a biomaterial surface is 
compared in the absence or presence of adhering bacteria [5]. The outcome of the 
competition between contaminating Staphylococcus epidermidis  ATCC 35983 and 
U2OS cells on glass appeared to be dependent on the number of bacteria adhering 
prior to mammalian cell seeding and the absence or presence of fluid flow. Cells lost 
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the competition in the absence of flow due to accumulation of bacterial toxins, but 
were able to grow under flow due to the continuous supply of fresh medium to and 
removal of endotoxins from the interface on all commonly used biomaterial surfaces 
[6]. Coverage of the surface by U2OS cells in the presence of adhering S. epidermidis 
was reduced however, as compared to cell surface coverage in the absence of 
adhering bacteria. 
In general, S. epidermidis and Staphylococcus aureus are the most frequently 
isolated pathogens from infected biomaterial implant surfaces. Additionally isolated 
organisms include Escherichia coli and Pseudomonas aeruginosa [2,7]. Almost 50% 
of infection associated with catheters, artificial joints and heart valves are caused by S. 
epidermidis [8], whereas S. aureus is detected in approximately 23% of infections 
associated with prosthetic joints [8]. P. aeruginosa is the causative organism of 
around 12% of hospital acquired urinary tract infections, 10% of bloodstream 
infections and 7% of hip joint infections [9].  
It is known that bacterial virulence is a contributing factor in the pathogenesis 
of BAI [10], but hitherto this aspect has not been included in our studies on the race 
for the surface, and experiments have been confined to S. epidermidis ATCC 35983. 
Therefore the aim of this study is to compare the influence of different strains of S. 
epidermidis, S. aureus and P. aeruginosa on the outcome of the competition between 
adhering bacteria and mammalian cells for the biomaterial surface in a peri-operative 
contamination model. 
 
Materials and Methods 
 
Biomaterial. Poly(methyl methacrylate) (PMMA) (Vink Kunststoffen, Didam, The 
Netherlands) was used as a substratum. Samples were rinsed thoroughly with ethanol 






(Merck, Darmstadt, Germany) and washed with sterile ultrapure water before use to 
yield a water contact angle of 73 ± 3 degrees [6].  
 
Mammalian cell culturing and harvesting. U2OS osteosarcoma cells were routinely 
cultured in Dulbecco’s modified Eagles Medium (DMEM)-low glucose supplemented 
with 10% fetal calf serum (FBS), 0.2mM ascorbic acid-2-phosphate (AA2P), denoted 
in the paper as “DMEM+FBS”. Cells were maintained at 37°C in a humidified 
atmosphere with 5% CO2, they were passaged at 70 – 90% confluency using 
trypsin/EDTA.  
 
Bacterial growth conditions and harvesting. The bacterial strains used in this study 
were S. epidermidis ATCC 35983, S. epidermidis ATCC 35984, S. epidermidis 3399, 
S. aureus ATCC 12600, S. aureus A20734, S. aureus 7388, P. aeruginosa DN7348, 
P. aeruginosa 01, P. aeruginosa ATCC 27853. First, a strain was streaked on a blood 
agar plate from a frozen stock and grown overnight at 37°C. The plate was then kept 
at 4°C. For each experiment, a colony was inoculated in 10 ml of tryptone soya broth 
(TSB; OXOID, Basingstoke, England) and cultured for 24 h. This culture was used to 
inoculate a second culture, which was grown for 17 h prior to harvesting. Bacteria 
were harvested by centrifugation at 5000 x g for 5 min at 10°C and washed twice with 
sterile ultrapure water. Subsequently, the harvested bacteria were sonicated on ice (3 x 
10 s) in sterile potassium phosphate buffer (PBS, 10 mM potassium phosphate, 0.15 
M NaCl, pH 7.0) in order to break bacterial aggregates. This suspension was further 
diluted in sterile PBS to a concentration of 3 x 106 bacteria per ml. Prior to the 
experiments, growth and biofilm formation of all bacterial strains in modified culture 
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medium (98% DMEM+FBS and 2% TSB [5]) was confirmed by culturing bacteria in 
this medium for 48 h. 
 
Competitive assay for mammalian cell growth and biofilm formation. The 
competitive assay was studied on the PMMA bottom plate of a parallel plate flow 
chamber (175 x 17 x 0.75 mm3), as described in detail before [5]. The flow chamber 
was equipped with heating elements and kept at 37°C throughout the experiments. 
Bacterial and U2OS deposition were observed with a CCD camera (Basler AG, 
Germany) mounted on a phase-contrast microscope Olympus BH-2 (Olympus, 
Germany) with a 40x objective for bacteria and 10x objective for mammalian cells. 
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, taking care to remove all air bubbles from the system. Once the system 
was filled, and before the addition of the bacterial suspension, PBS was allowed to 
flow through the system at a shear rate of 11 s-1. Then, a bacterial suspension in PBS 
was perfused through the chamber at the same shear rate and phase-contrast images 
were obtained. As soon as the desired density of adhering bacteria (103 cm-2), was 
reached, flow was switched to sterile PBS to remove the bacterial suspension from the 
tubes and chamber. Subsequently, a U2OS cell suspension (1.2 × 105 cells ml-1) in 
modified culture medium (98% DMEM+FBS and 2% TSB) was allowed to enter the 
flow chamber. Once the entire volume of buffer inside the chamber was replaced by 
the cell suspension, flow was stopped for 1.5 h in order to allow U2OS cells to adhere 
and spread on the substratum surface. Subsequently, phase contrast images (nine 
images, 900 x 700 µm each) were taken and the number of adhering cells per unit area 
as well as the area per spread cell were determined using Scion image software. 
Finally, modified culture medium supplemented with 2% HEPES was perfused 






through the system at a low shear rate of 0.14 s-1 for 48 h and phase-contrast images 
were obtained continuously.  
 
Immuno-cytochemical staining and determination of cell surface coverage. After 
48 h of flow, the surfaces were prepared for immuno-cytochemical staining to assess 
the mammalian cell morphology and spreading. For fixation, surfaces with adhering 
bacteria and U2OS cells were placed in a Petri dish with 30 ml of 3.7% formaldehyde 
in cytoskeleton stabilization buffer (CS; 0.1 M Pipes, 1 mM EGTA, 4% (w/v) 
polyethylene glycol 8000, pH 6.9). After 5 min, the fixation solution was replaced by 
30 ml of fresh CS for another 5 min. Subsequently U2OS cells were incubated in 
0.5% Triton X-100 for 3 min, rinsed with PBS and stained for 30 min with 5 ml PBS 
containing 49 µl DAPI and 2 µg ml-1 of TRITC-Phalloidin. The U2OS cells on the 
surfaces were washed four times in PBS and examined with confocal laser scanning 
microscopy (CLSM, Leica DMRXE with confocal TCS SP2 unit). Images (nine 
images on different locations, 900 x 700 µm each) were taken. The number of 
adhering U2OS cells per unit area and the average area per spread cell were 
determined using Scion image software to yield the total coverage of the substratum 
surface by mammalian cells.  
 
Statistics. Data are presented as a mean with standard deviation. Statistical ANOVA 












Immediately after seeding, U2OS cell adhesion and spreading was observed in the 
absence and presence of adhering bacteria on PMMA. After 1.5 h, the average 
number of adhering U2OS cells on the PMMA surface was 2.5 × 104 cells cm-2 with 
an average area of 500 µm2 per cell. The spreading of U2OS cells on the PMMA 
surface after 1.5 h was not significantly different in the absence or presence of 
adhering bacteria, regardless of the strain involved. After 18 h of growth, U2OS cell 
death was observed on PMMA in the presence of adhering S. aureus and P. 
aeruginosa strains, whereas no cell death was observed in the presence of adhering S. 
epidermidis strains (Fig. 1). The simultaneous growth of U2OS cells and S. 
epidermidis was subsequently observed for a period of 48 h.  
 
Fig. 1. Phase contrast images of U2OS cells after 18 h of growth in the presence of adhering 
bacteria (a – S. epidermidis ATCC 35983, b – S. aureus ATCC 12600 and c – P. aeruginosa 
ATCC 27853) on PMMA surfaces. Fig. 1a, U2OS cells are differentiated by a contour line 
from S. epidermidis biofilm. White arrows in Figs. 1b and 1c indicate U2OS cell death. The 
bar denotes 10 µm. 
 






After 48 h of simultaneous growth of cells and bacteria, the adhering U2OS 
cells were immunocyto-stained for CLSM analysis to derive the number and spread 
area of adhering U2OS cells in the absence and presence of the different S. 
epidermidis strains. No U2OS cells were detected after 48 h of growth in the presence 
of adhering S. aureus and P. aeruginosa. In Fig. 2 it can be seen that the percentage 
increase in number of adhering U2OS cells was significantly reduced (p < 0.01) due 
to the presence of S. epidermidis as compared to the absence of adhering bacteria. The 
reduction in U2OS cell adhesion was larger (p < 0.01) in the presence of S. 
epidermidis 3399 and S. epidermidis ATCC 35984 as compared to S. epidermidis 
ATCC 35983 (p < 0.05). Adhering U2OS cells showed no significant difference in 
spreading on PMMA in the presence of adhering S. epidermidis as compared to the 
absence of adhering staphylococci (Fig. 3).  
  
Fig. 2. Percentage increase in the number of adhering U2OS cells after 48 h of growth with 
respect to their initial number immediately after seeding at 1.5 h on PMMA in the absence (no 
bacteria) and presence of adhering bacteria. Error bars represent the standard deviations over 
three replicates, with separately cultured bacteria and mammalian cells. Cell number in the 








Fig. 3. Average area per adhering U2OS cell immediately after seeding at 1.5 h (□) and after 
48 h (■) of growth on PMMA in the absence (no bacteria) and presence of adhering bacteria. 
Error bar represents the standard deviation over three replicates, with separately cultured 
bacteria and mammalian cells.  
 
In the concept of the race for the surface, the total cell surface coverage of the 
substratum surface by tissue cells is considered determinant for the fate of a 
biomaterial implant. The surface coverages by U2OS cells at 1.5 h after seeding and 
after 48 h of growth are shown in Fig. 4. The surface coverage by adhering U2OS 
cells 1.5 h after seeding varied between 11% and 16% regardless of the absence or 
presence of adhering bacteria. The cell surface coverage increased significantly after 
48 h in the absence and in the presence of adhering S. epidermidis. In the presence of 
adhering S. aureus and P. aeruginosa, reductions in cell surface coverages were 
observed after 18 h of growth, indicating U2OS cell death and no U2OS cells were 
detected on the PMMA surface after 48 h (Fig. 5).  







Fig. 4. Surface coverage by adhering U2OS cells immediately after seeding at 1.5 h (□) and 
48 h (■) of growth on PMMA in the absence (no bacteria) and presence of adhering bacteria. 
Error bar represents the standard deviation over three replicates, with separately cultured 
bacteria and mammalian cells. Surface coverage by U2OS cells after 48 h in the presence of 
adhering bacteria are significantly different (p < 0.05) from the absence of bacteria. 
 
 
Fig. 5. An example of surface coverage by adhering U2OS cells as a function of time on 
PMMA in the presence of adhering bacteria ((▲) – S. epidermidis 3399, (■) – S. aureus 




This paper presents the first experimental comparison of the influence of different 
pathogens on the outcome of the race between adhering bacteria and mammalian cells 
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for a biomaterial surface. In our in vitro model, bacteria were allowed to adhere prior 
to cell adhesion and spreading, which mimics the situation of peri-operative bacterial 
contamination of implant surfaces. The number of bacteria adhering on the PMMA 
surface prior to initiating mammalian cell adhesion and spreading was set to 103 cm-2. 
In the past, it has been documented that during a surgical procedure of 1 h, the total 
number of bacteria carrying particles falling on a wound is about 270 cm-2. The 
bacterial counts are generally higher during periods of activity and when more people 
are present in the operation theatre [11]. More recent, through the use of modern, 
better ventilated operation theatres (20 changes of air per hour) and impermeable 
patient and personnel clothing, peri-operative bacterial contamination may well be 
less [12]. However, many surgical procedures in which implants are introduced in the 
body last much longer than 1 h. Therefore, the level of bacterial contamination chosen 
in our experiments is probably realistic of  a worst case scenario. Despite these low 
numbers, peri-operatively introduced organisms, particularly when of low virulence, 
can survive on an implant surface for prolonged periods of time and later, during 
periods of host immune depression, they proliferate and establish an infection with 
clinical symptoms [13].  
In the concept of the race for the surface, full coverage of a biomaterial surface 
in vivo protects an implant against bacterial colonization [4]. Previously, in our model 
for the ‘race for the surface’, all common biomaterial surfaces, including PMMA, 
allowed S. epidermidis ATCC 35983 biofilm formation with a negative impact on the 
coverage of the biomaterial surface by mammalian cells [6]. Yet, PMMA showed 
better mammalian cell adhesion and spreading in the presence of adhering S. 
epidermidis ATCC 35983 than other commonly used biomaterials [6]. The present 
study confirms that U2OS cells are able to adhere, spread and grow in the presence of 






different S. epidermidis strains, but not in the presence of adhering S. aureus or P. 
aeruginosa. The latter strains cause death of all adhering U2OS cells within 18 h, 
despite removal of bacterial toxins by flow.  
These observations are in line with clinical findings that BAI due to S. aureus 
and P aeruginosa usually progresses much more aggressively than BAI caused by S. 
epidermidis. S. aureus appears more frequently in acute infections, within 4 weeks of 
surgery, of complicated total joint arthroplasty compared to S. epidermidis. S. 
epidermidis is most commonly implicated in delayed septic loosening of total joint 
prostheses [14] or even in presumed a-septic loosening [15], indicating its low 
virulence with only minor clinical symptoms of infection. Pseudomonas is also much 
more virulent than S. epidermidis, which is ascribed to the more aggressive 
endotoxins in the slime. Pseudomonas slime injected into mice produces liver and 
renal dysfunction and death within a short time, while no such effect was seen with S. 
epidermidis slime [16,17]. In vascular grafts, pacemakers and orthopedic devices, S. 
epidermidis is mostly found in low grade infections and a common cause of late 
infections. In patients with low grade hip implant infections, only 5% of the patient 
had a temperature of 37.8°C or higher and only 20% had wound drainage [18]. 
Buchholz and co-workers [19] showed that 84% of 64 patients with an infection by a 
low virulent organism, were free from infection 2 years later. Alternatively, when S. 
aureus was the causal organism, recurrent infection occurred in 28% of the patients 
[19], and almost 50% of the patients with a Gram-negative bacterial infection 
(Pseudomonas) experienced recurrent infection. This suggested a direct correlation 
between the clinical outcome and the causative bacterial strain, in line with our in 
vitro results.  
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The low virulence of S. epidermidis strains compared to S. aureus or P. 
aeruginosa is due to the lack of additional genes responsible for producing severely 
tissue damaging toxins [8,9,20]. In S. epidermidis infections, biofilm formation is 
considered the only virulence factor and therefore infections are usually sub-acute or 
chronic [21-23]. Amongst the S. epidermidis strains involved in this study, S. 
epidermidis ATCC 35983 was considered not to produce slime, while S. epidermidis 
3399 and S. epidermidis ATCC 35984 were slime producers [24]. Interestingly, a 
significant reduction in number of adhering U2OS cells was observed in the presence 
of S. epidermidis ATCC 35984 and S. epidermidis 3399 compared to S. epidermidis 
ATCC 35983 in direct correlation to the slime producing capability of these strains.  
This study demonstrates that U2OS cells are bound to lose the race for the 
surface in the presence of adhering, highly virulent S. aureus or P. aeruginosa strains, 
whereas spreading and growth of adhering U2OS cells, although impaired, still occurs 
in the presence of adhering S. epidermidis strains. These results are in line with the 
clinically documented progression of BAI by the different species included in this 
study and highlight the potential use of our in vitro model for studies investigating the 
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Biomaterial-associated-infections (BAI) remain a major cause of failure of 
biomaterial implants. Biomaterial implants may become contaminated with 
microorganisms during implant surgery (peri-operative contamination) or during 
hospitalization [1], causing the onset of BAI. Microorganisms involved in BAI are 
protected from antibiotics due to their biofilm mode of growth. Consequently, 
infected implants often have to be removed and a new implant can only be inserted 
once complete eradication of the infected surrounding tissue has been performed. 
Successful tissue integration depends on the outcome of the race for the surface 
between microorganisms and tissue cells [1]. If this race is won by tissue cells, then 
the biomaterial surface is covered by a cellular layer and is less vulnerable to biofilm 
formation. On the other hand, if the race is won by bacteria, the implant surface will 
become colonized by bacteria, and tissue cell functions are hampered by bacterial 
virulence factors [2]. Since microorganisms are frequently introduced on an implant 
surface during surgery, microorganisms often start the race for the surface before 
tissue integration can even occur [2].  
Biofilm formation occurs on all currently used biomaterials. Microbial 
adhesion to biomaterials is determined by the physicochemical properties of the 
implant surface [3]. Thus, modification of an implant surface may be able to prevent 
bacterial adhesion and biofilm formation. Several surface modification methods [4-6], 
such as hydrophilic polymer brush-type surfaces (in particular poly(ethylene glycol) 
PEG), have been developed to prevent bacterial adhesion and biofilm formation [7]. 
However, such non-adhesive polymer coatings also resist adhesion, spreading and 
growth of mammalian cells [6,8], which are required for successful tissue integration.  
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In order to prepare bi-functional coatings which prevent microbial adhesion 
while supporting tissue cell growth, the biologically inert poly(L-lysine)-graft-
poly(ethylene glycol) (PLL-g-PEG) copolymer was modified with the arginine-
glycine-aspartic acid (RGD) peptide sequence [8]. The RGD peptide is known as one 
of the major recognition sites of integrin receptors through which mammalian cells 
connect to their extracellular matrix molecules [9]. In earlier studies, reduced bacterial 
adhesion on bi-functional PLL-g-PEG/PEG-RGD-modified surfaces has been 
demonstrated separately from their ability to support mammalian cell growth [7,10]. 
However, a simultaneous study on bacterial biofilm formation and mammalian cell 
growth, i.e. an actual “race for the surface”, has not been performed due to lack of 
proper methodology. Recently, an in vitro experimental methodology to investigate 
bacterial biofilm formation and mammalian cell growth in a single experiment was 
developed [11]. The outcome of the competition between Staphylococcus epidermidis 
and U2OS cells appeared to be dependent on the number of bacteria present prior to 
cell seeding and the absence or presence of fluid flow. Mammalian cells lost the 
competition in the absence of flow due to the accumulation of bacterial toxins, but 
were able to grow under flow due to the continuous supply of fresh medium to and 
removal of endotoxins from the interface. A further study of the race for the surface 
on different biomaterials demonstrated that mammalian cell interactions with 
biomaterials were hampered by bacterial biofilm formation on all commonly used 
biomaterial surfaces [12]. 
This study aimed at evaluating titanium oxide surfaces modified with 
biopassive PLL-g-PEG and bioactive PLL-g-PEG/PEG-RGD with respect to biofilm 
formation and simultaneous mammalian cell adhesion, spreading and growth. In 






particular the hypothesis that the bi-functional, bioactive surface may favour 
mammalian cell interaction over biofilm formation, is tested.  
 
Materials and Methods 
 
TiO2-coated glass slides. Microscope glass slides (76 × 26 mm) were purchased from 
Menzel GmBH+Co KG, Braunschweig, Germany. The glass slides were sputter-
coated with a 21 nm thick TiO2 layer (reactive magnetron sputtering, Paul Scherrer 
Institute, Villigen, Switzerland). 
 
PLL-g-PEG and PLL-g-PEG/PEG-RGD. PLL-g-PEG and PLL-g-PEG/PEG-RGD 
were purchased from Surface Solutions, AG, Switzerland. PLL-g-PEG is a copolymer 
with a polycationic PLL backbone onto which non-functionalized (methoxy-
terminated) PEG chains are grafted. Grafting ratio, expressed as g, represents the ratio 
between number of lysine units and number of grafted PEG chains (g = Lys/PEG). 
PLL-g-PEG/PEG-RGD describes a copolymer with a PLL backbone onto which two 
different types of PEG chains are grafted, i.e. non-functionalized PEG and RGD-
functionalized PEG [8].  
The molecular weights of PLL, non-functionalized PEG and RGD-
functionalized PEG, are 20 kDa, 2 kDa, and 3.4 kDa, respectively. The grafting ratio 
(g) of both copolymers PLL-g-PEG and PLL-g-PEG/PEG-RGD is 3.5. For the latter, 
8% of all PEG chain carry the terminal, covalently linked peptide 
GCRGYGRGDSPG. 
 
Surface preparation and polymer adsorption. The copolymers were dissolved at a 
0.25 mg ml-1 concentration in HEPES II buffer (10 mM HEPES and 150 mM NaCl, 
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adjusted to pH 7.4 by addition of NaOH). The polymer solutions were filter-sterilized 
(0.22 µm filter), aliquoted and stored at -20°C until use. Prior to surface modification, 
TiO2-coated glass slides were ultrasonicated for 10 min in a cleansing solution (300 
mM hydrochloric acid and 1% detergent, Cobas Integra®, Roche Diagnostic, 
Indianapolis, USA), rinsed with ultra pure water, followed by 10 min ultrasonication 
in 2-propanol to remove the adventitious macroscopic contamination and blow-drying 
under a stream of nitrogen. Subsequently, the TiO2-coated glass slides were cleaned 
by means of oxygen plasma treatment for 2 min (Plasma cleaner/sterilizer PDC-32G, 
Harrick scientific products Inc., USA). Copolymer solutions were subsequently 
placed onto the pre-cleaned substrates completely covering their surfaces. Copolymer 
adsorption was allowed to proceed for 1 h to provide a complete monolayer on the 
surface, followed by extensive washing with HEPES II buffer, ultrapure water, and 
finally blow-drying under a stream of nitrogen. Data on conformation of the used 
copolymers adlayers and interaction with proteins have been described elsewhere 
[13]. 
The copolymer-modified substrates were placed in a clean sample holder and 
stored at 4°C until use. The surfaces are denoted as “TiO2” for bare titanium oxide 
surface, “PEG” for PLL-g-PEG-modified and “PEG-RGD” for PLL-g-PEG/PEG-
RGD-modified surface. The surfaces were sterilized using 70% ethanol and washed 
with sterile ultrapure water before use. 
 
Bacterial growth conditions and harvesting. S. epidermidis ATCC 35983, 
originally isolated from human blood of a patient with an infected intravascular 
catheter, and known to produce polysaccharide integrin adhesin [14], was used 
throughout this study. First, the strain was streaked on a blood agar plate from a 






frozen stock and grown overnight at 37°C. The plate was then kept at 4°C. For each 
experiment, a colony was inoculated in 10 ml of tryptone soya broth (TSB; OXOID, 
Basingstoke, England) and cultured for 24 h. This culture was used to inoculate a 
second culture, which was grown for 17 h prior to harvesting. Bacteria were harvested 
by centrifugation at 5000 x g for 5 min at 10°C and washed twice with sterile 
ultrapure water. Subsequently, the harvested bacteria were ultrasonicated on ice (3 x 
10 s) in sterile PBS (10 mM potassium phosphate, 0.15 M NaCl, pH 7.0) in order to 
break bacterial aggregates. This suspension was further diluted in sterile PBS to a 
concentration of 3 x 106 bacteria per ml. 
 
Mammalian cell culturing and harvesting. U2OS osteosarcoma cells were cultured 
in Dulbecco’s modified Eagles Medium (DMEM)-low glucose supplemented with 
10% fetal calf serum (FBS) and 0.2 mM of ascorbic acid-2-phosphate (AA2P) without 
antibiotics, denoted “DMEM+FBS”. Osteoblasts were maintained at 37°C in a 
humidified 5% CO2 atmosphere, and passaged at 70 – 90% confluency using 
trypsin/EDTA.  
 
Bacteria and tissue cell competitive adhesion assays. Competitive adhesion assays 
were performed on the bottom plate of a parallel plate flow chamber (175 x 17 x 0.75 
mm3) prepared from the biomaterial surfaces with or without polymer coatings under 
investigation, as described in detail elsewhere [11]. Importantly, the flow chamber 
was equipped with heating elements and kept at 37°C throughout the experiments. 
Bacterial and U2OS cell deposition were observed with a CCD camera (Basler AG, 
Germany) mounted on a phase-contrast Leica DM2000 microscope (Leica 
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Microsystems Ltd, Germany) with a 30x objective for bacteria and 10x objective for 
mammalian cells. 
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, to ensure all air bubbles were removed from the system. Prior to the 
addition of bacterial suspension, sterile PBS was allowed to flow through the system 
at a shear rate of 11 s-1. Subsequently, the bacterial suspension in PBS was perfused 
through the chamber at the same shear rate for 2 h. Images were obtained 
continuously and the number of bacteria per unit area were analyzed in real-time by 
using proprietary software based on the Matlab Image processing Toolkit (The 
MathWorks, MA, USA). The flow with shear rate of 11 s-1 was then re-initiated to 
deliver sterile PBS to remove unattached bacteria from the tubes and flow chamber, 
after which a U2OS cell suspension (6 × 105 cells ml-1) in modified culture medium, 
consisting of 98% DMEM+FBS and 2% TSB which is suitable for the simultaneous 
growth of U2OS cells and S. epidermidis [11], was allowed to enter the flow chamber. 
Once the entire volume of buffer inside the chamber was replaced by the cell 
suspension, the flow was stopped for 1.5 h in order to allow tissue cells to adhere and 
spread on the substratum. Subsequently, phase contrast images (nine images on 
different locations, 900 x 700 µm2 each) were taken to determine the number of 
adhering cells per unit area and the area per spread cell using Scion image analysis 
software. Finally, modified culture medium supplemented with 2% HEPES was 
perfused through the system at a low shear rate of 0.14 s-1 for 48 h, and phase-contrast 
images were collected continuously. After 48 h of growth, the shear stress was 
increased to 5.6 s-1 for 30 min, i.e. a value that is lower than the one used during 
initial bacterial adhesion (11 s-1). Subsequently, U2OS cells and bacterial biofilm 






growth were monitored continuously. Control experiments with only U2OS cells (in 
the absence of S. epidermidis) were performed using the above procedure. 
Finally, the adhering U2OS cells were stained with TRITC-Phalloidin for 
quantitative analysis. Briefly, the substrate surfaces with adhering bacteria and tissue 
cells were fixed with 30 ml of 3.7% formaldehyde in cytoskeleton stabilization buffer 
(CS; 0.1 M Pipes, 1 mM EGTA, 4% (w/v) polyethylene glycol 8000, pH 6.9). After 5 
min, the fixation solution was replaced with 30 ml of fresh CS for another 5 min. 
Subsequently, U2OS cells were incubated in 0.5% Triton X-100 for 3 min, rinsed 
with PBS, stained for 30 min with 5 ml PBS containing 49 µl DAPI and 2 µg ml-1 of 
TRITC-Phalloidin, washed four times in PBS and examined with confocal laser 
scanning microscopy (CLSM, Leica DMRXE with confocal TCS SP2 unit equipped 
with a water immersion lens). Images (nine images on different locations, 900 x 700 
µm2 each) were taken and the number of adhering cells per unit area and the average 
area per spread cell were determined.  
 
Statistics. Experiments on different surfaces were performed in triplicate. Data are 
represented as a mean with standard deviation. For statistical analysis ANOVA was 
performed followed by a Tukey’s HSD post-hoc test and a p-value < 0.05 was 
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Bacterial adhesion. Initial adhesion of S. epidermidis after 2 h of flow at a shear rate 
of 11 s-1 was significantly reduced to 3.6±1.8 × 103 cm-2 and 6.0±3.9 × 103 cm-2 on 
both PEG and PEG-RGD coatings respectively, compared to 1.3±0.4 × 105 cm-2 on 
the bare TiO2 surface (Fig. 1). This demonstrates that in the presence of RGD-peptide 
sequences, the non-adhesive functionality of the PEG brush surface is still maintained.  
  
Fig. 1. The number of adhering S. epidermidis ATCC 35983 as a function of time in a parallel 
plate flow chamber (shear rate 11 s-1) on mono-functional PEG coating (○) and a bi-functional 
PEG-RGD coating (□) as well as on a bare TiO2 surface (▲). Error bars represent the 
standard deviation over three replicates with separately cultured bacteria.  
 
U2OS cell adhesion and spreading in the absence and presence of adhering S. 
epidermidis. Immediately after seeding, U2OS cell adhesion and spreading was 
observed in the absence and presence of adhering S. epidermidis on TiO2 surfaces and 
PEG-RGD coatings, but not on the PEG coatings. At 1.5 h, there was no significant 
difference in the number of adhering U2OS cells on the different surfaces (Table 1), 
but cell spreading was greater on PEG-RGD coatings, as compared to PEG coatings 
and TiO2 surfaces (p<0.01), irrespective of absence or presence of S. epidermidis 




Table 1: Number of cells, area of spread cells and surface coverage of U2OS cells on TiO2, PEG and PEG-RGD surfaces after initial seeding at 1.5 h and 
after 48 h of growth at a shear rate of 0.14 s-1 and subsequent application of an elevated shear rate (5.6 s-1) for 30 min, in the absence and presence of 
adhering S. epidermidis. ± indicates the standard deviation over three independently prepared and measured samples.  
 
 
Absence of S. epidermidis 
 
 







































































56±9 875±50 1180±82 36±4 69±11 43±3 50±9 1070±35 1024±96 44±4 54±10 
* no U2OS cells were detected on the surface. 
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After 48 h, the adhering S. epidermidis had grown into a biofilm on all 
surfaces, but simultaneously U2OS cell adhesion and spreading was observed on TiO2 
surfaces and PEG-RGD coatings (Fig. 2). On PEG coatings, U2OS cells that were 
loosely adhered retained a rounded morphology up to 48 h (Fig. 2e). Upon application 
of an elevated shear rate (5.6 s-1), biofilms detached from PEG and PEG-RGD 
coatings and partially from TiO2 surfaces, whereas U2OS cell detachment only 
occurred from the PEG coating (Fig. 2g,h and i).  
 
Fig. 2. Phase-contrast images of U2OS cell adhesion and spreading after seeding at 1.5 h, 
after 48 h of growth at low shear (0.14 s-1) in the presence of adhering S. epidermidis as well 
as after an elevated shear (5.6 s-1) for 30 min at the end of the experiment, on PEG and PEG-
RGD coatings, and on TiO2 control surfaces. At 1.5 h, well spread U2OS cells were observed 
on PEG-RGD (c) compared to PEG coating (b) and TiO2 control surfaces (a), for which cell 
spreading was less. At 48 h, biofilm formation and U2OS cell spreading were observed on 
TiO2 control surface (d) and PEG-RGD coating (f), whereas only biofilm formation and no 
cell spreading were seen on PEG coating (e). Upon application of an elevated shear, 
detachment of biofilm and U2OS cells was observed on PEG coatings (h), while only biofilm 
detachment occurred on PEG-RGD coating (i) and TiO2 surface (g). All images were taken at 
the same magnification. The bar denotes 10 µm.  
 
After 48 h of growth and subsequent application of a higher shear, adhering 
U2OS cells were immunocyto-stained for CLSM analysis (Fig. 3) to derive the 
number and spread area of adhering U2OS cells in the absence and presence of 
staphylococci. In Fig. 4 it can be seen that on a percentage basis, the number of 






adhering U2OS cells was significantly reduced on TiO2 surfaces in the presence of S. 
epidermidis as compared to the control, i.e. in the absence of adhering bacteria (p < 
0.05). In the presence of S. epidermidis, the percentage adhering U2OS cells 
decreased on TiO2 surfaces in contrast to that on bi-functional PEG-RGD coatings 
(Fig. 4) which showed an increase. U2OS cells showed no significant difference in 
spreading on PEG-RGD coating as compared to a TiO2 surface in the presence or 
absence of adhering S. epidermidis (Fig. 5 and Table 1).  
 
Surface coverage of U2OS cells in the absence and presence of adhering S. 
epidermidis. Immediately after seeding at 1.5 h, a significant increase in the surface 
coverage of U2OS cells was observed on PEG-RGD coatings compared to TiO2 
surfaces and PEG coatings, irrespective of the absence or presence of adhering S. 
epidermidis (Table 1).  
 
Fig. 3. CLSM images of U2OS cells after 48 h of growth at low shear (0.14 s-1) and 
subsequent application of an elevated shear (5.6 s-1) for 30 min on TiO2 surfaces, PEG and 
PEG-RGD coatings in the absence (a-c) and presence (d-f) of adhering S. epidermidis. U2OS 
cells were stained with 5 ml PBS containing 49 µl DAPI and 2 µg ml-1 of TRITC-phalloidin. 
All images were taken at the same magnification. The bar denotes 75 µm.  
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After 48 h of growth at low shear and subsequent application of an elevated shear for 
30 min, TiO2 surface showed a significant decrease in surface coverage in the 
presence of adhering staphylococci compared to the control, i.e. the absence of 
adhering staphylococci. On PEG coatings, no adhering U2OS cells were detected on 
the surface (Fig. 3b,e). Conversely PEG-RGD coatings in the presence of adhering 
staphylococci showed no significant difference in surface coverage of U2OS cells 
compared to cells cultured in the absence of S. epidermidis. 
 
  
Fig. 4. The percentage increase in the number of adhering U2OS cells after 48 h of growth at 
low shear (0.14 s-1) and subsequent application of an elevated shear (5.6 s-1) for 30 min with 
respect to their initial number immediately after seeding at 1.5 h on TiO2 surfaces and PEG 
and PEG-RGD coatings in the absence (□) and presence (■) of adhering S. epidermidis ATCC 
35983. Error bars represent the standard deviations over three replicates, with separately 
cultured bacteria and tissue cells.  
 ×   denotes significance at p < 0.01,  denotes significance at p < 0.05. 
 







Fig. 5. The average area per adhering U2OS cell immediately after seeding at 1.5 h (□) and 
after 48 h of growth at low shear (0.14 s-1) and subsequent application of an elevated shear 
(5.6 s-1) for 30 min (■) on TiO2 surfaces, PEG and PEG-RGD coatings in the absence and 
presence of adhering S. epidermidis ATCC 35983. Error bars represent the standard 
deviations over three replicates, with separately cultured bacteria and tissue cells. 




This paper is the first to experimentally demonstrate the advantage of bi-functional 
versus mono-functional coatings in the prevention of infection on implant surfaces by 
conducting the race for the surface between bacteria and mammalian cells, as 
eventually determining the fate of a biomaterial implant. Bi-functional coatings 
clearly remained non-adhesive to S. epidermidis, but at the same time supported 
mammalian cell adhesion and spreading to a greater extent than mono-functional 
coatings and a control surface, in this case a bare TiO2 surface. Titanium is widely 
used in dental and orthopaedic implants, heart valves and vascular stents [15]. 
Titanium devices implanted in the body are covered with a layer of oxide, responsible 
for the favourable biocompatibility of titanium implants. Tissue cells reactions on 
TiO2 and pure titanium are very similar [16].  
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In our in vitro model, bacteria were allowed to adhere for 2 h prior to cell 
adhesion and spreading, which is considered to mimic the clinical situation where 
implants become contaminated prior to implantation. The number of bacteria adhering 
on PEG and PEG-RGD was 103 cm-2 and 105 cm-2 for TiO2, representing a reduction 
in initial bacterial load on polymer brush coatings of two log-units. Note that in this 
study we deliberately chose to fix the time for bacterial adhesion, and not to 
contaminate all surfaces with the same number of organisms. This choice allows to 
compare coatings and surfaces for their performance during a fixed surgical period. In 
the past, it has been documented that during a surgical procedure of 1 h, the total 
number of bacteria carrying particles falling on the wound is about 270 per cm2 [17]. 
The bacterial counts are generally higher during periods of activity and when more 
people are present in the operation theatre. More recent, through the use of modern, 
better ventilated operation theatres (20 changes of air per hour) and impermeable 
patient and personnel clothing, peri-operative bacterial contamination may well be 
less [18]. However, many surgical procedures in which implants are introduced in the 
body last much longer than 1 h. Therefore, the bacterial adhesion densities chosen in 
our experiments represent a moderate to worst case scenario.  
Significant reduction of bacterial adhesion on PEG and PEG-RGD-coated 
surfaces compared to that on bare TiO2 surface was previously reported [7]. In earlier 
studies [19,20], it was reported that the presence of a peptide covalently attached to 
PEG reduced bacterial adhesion similar to PEG coatings. In agreement with previous 
studies our results show that S. epidermidis showed no significant difference in 
adhesion on PEG coatings compared to PEG-RGD coatings indicating that the S. 
epidermidis ATCC 35983 bacteria do not recognize the RGD, unlike mammalian cells 
recognize RGD via integrin receptors.  






Cell adhesion to a biomaterial surface is a prerequisite for successful tissue 
integration. Mammalian cells bind to the biomaterial surface through adsorbed 
proteins and one of the main binding sites in these proteins is the RGD peptide 
sequence [21]. On PEG coatings, hardly any protein adsorbed resulting in an 
inhibition of cell adhesion and spreading [6,22]. Similarly, in our experiments U2OS 
cells remained rounded on mono-functional PEG coatings up to 48 h. Such anti-
fouling behaviour is mainly due to steric repulsion between the hydrated uncharged 
PEG chains and proteins [23]. However cell adhesion to mono-functional PEG-
coatings can be achieved by introducing specific bioligands, such as a cell-interactive 
peptide (RGD) linked covalently to the non-fouling PEG, producing a bi-functional 
PEG-RGD coating. Our results show an enhanced mammalian cell adhesion to the bi-
functional PEG-RGD coatings, in which already within 1.5 h after cell seeding, the 
U2OS cells showed near maximum spreading, indicating recognition of the RGD-
sequence by adhesion receptors in the cell membrane [24]. The enhanced cell 
attachment and spreading depends on the RGD-peptide surface density [25]. The 
RGD-peptide surface density of around 5 pmol RGD peptide per cm2 applied here 
was well above reported densities for cell adhesion of over 0.6 pmol RGD peptide per 
cm2 [26]. The former was calculated [27] based on the copolymer composition (RGD 
grafting density, NMR) and the adsorbed copolymer mass from in situ monitoring of 
the copolymer adsorption using Optical Waveguide Lightmode Spectroscopy 
(OWLS) (data not shown).  
In the concept of the race for the surface, a full coverage of a biomaterial in 
vivo by a viable tissue cell layer, intact cell membranes and functional host defense 
mechanisms resist bacterial colonization [28]. Previously, in our model for the ‘race 
for the surface’, all biomaterial surfaces allowed bacterial adhesion and biofilm 
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growth with a negative impact on the coverage of the biomaterial by mammalian cells 
[12]. Similarly, the presence of adhering S. epidermidis decreased the surface 
coverage of U2OS cells on TiO2 surface compared to their control, i.e. the absence of 
S. epidermidis. In contrast to the TiO2 surface, the presence of RGD-peptides at the 
surface significantly improved U2OS cell adhesion and spreading in the presence of S. 
epidermidis, eventually resulting in similar surface coverage than the control, i.e. the 
absence of S. epidermidis. Considering that cell adhesion and spreading are the signs 
of cellular well-being, this is highly indicative for a protective effect of cell binding to 
RGD in the presence of bacteria [29]. Even though complete coverage of the 
biomaterial surface was not obtained after 48 h, significantly improved U2OS cell 
adhesion and spreading on PEG-RGD coatings could eventually lead to complete 
coverage of U2OS cells on biomaterial surfaces over longer periods of time. In the 
concept of the race for the surface, one may speculate that PEG-RGD coated implants 
will become more easily integrated by host tissue cells than other biomaterial surfaces 
and thus better protect the implant against infection.  
PEG coatings have been shown to be resistant to protein adsorption, biofilm 
formation and cell attachment in vitro over periods of up to 4 weeks [8, 30-32]. 
Depending on the exact nature of the coating, degradation of this biocompatible 
polymeric monolayer by hydrolytic/enzymatic activity has been reported. Another 
concern is the mechanical robustness of the PEG coatings, and if handled with 
surgical instruments, coatings may be easily damaged. Optichem® [32] and nano-
particle based polymer brush coatings [31] are mono-functional non-adhesive coatings 
with greater robustness than can be obtained with monolayer coatings, like the PEG-
RGD coating evaluated here. The results of the present study, however, aid in 
directing such further development of monolayer bi-functional coatings into more 






robust ones, suitable for clinical use. The early protection by bi-functional coatings is 
believed to be clinically relevant, as it could prevent an implant from becoming 
colonized during the important period of actual implantation, which is critical for the 




This study demonstrates that biopassive, mono-functional PEG coatings and 
bioactive, bi-functional PEG-RGD coatings have potential to reduce bacterial 
adhesion and prevent firm adhesion of biofilms compared to common biomaterial 
surfaces. Moreover, in contrast to mono-functional PEG coatings, bi-functional PEG-
RGD coatings allow cell adhesion and spreading. At the same time, adhesion and 
spreading of mammalian cells is not detrimentally affected by the presence of 
adhering S. epidermidis. Bi-functional coatings thus have a strong potential to reduce 
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Biomaterial-associated infections (BAI) can develop from peri-operative microbial 
contamination of implant surfaces during implantation, immediately post-surgery 
during hospitalization or by late haematogenous spreading from infections elsewhere 
in the body. Both peri-operative and post-operative contaminations can cause BAI 
many years after implantation, as bacteria can stay dormant on an implant surface for 
several years [1,2]. Microorganisms involved in BAI are resistant to antibiotics and 
the host immune system due to their biofilm mode of growth, and biomaterial 
implants with a biofilm have to be removed in most cases [3-5]. Irrespective of the 
route of infection, the fate of a biomaterial implant depends mainly on the outcome of 
the so-called ‘race for the surface’ between successful tissue integration of the 
biomaterial implant and biofilm growth [6]. If this race is won by tissue cells, then the 
biomaterial surface is fully integrated by tissue cells and less vulnerable to bacterial 
biofilms. On the other hand, if the race is won by bacteria, the implant surface will 
become colonized by bacteria and tissue cell functions are hampered by bacterial 
virulence factors and toxins [6,7]. In the concept of the race for the surface, a full 
surface coverage of a biomaterial in vivo by a viable tissue cell layer, intact cell 
membrane and functional host defense mechanisms resist bacterial colonization [8]. 
 Previously an in vitro experimental model for peri-operative bacterial 
contamination of implant surfaces was forwarded and the effects of bacterial presence 
on adhesion, spreading and growth of mammalian cells were determined in a single 
experiment [9]. The outcome of the race for the surface between contaminating 
Staphylococcus epidermidis and mammalian cells on glass appeared to be dependent 
on the number of bacteria present prior to mammalian cell seeding and the absence or 
presence of fluid flow. Cells lost the race for the surface in the absence of flow due to 
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accumulation of bacterial toxins, but were able to grow under flow due to the 
continuous supply of fresh medium to and removal of endotoxins from the interface 
on all commonly used biomaterial surfaces [10]. 
In the concept of the race for the surface, as forwarded by the late orthopedic 
surgeon A.G. Gristina, tissue integration is an important protective factor against 
bacterial contamination of an implant surface [8]. However, the degree of tissue 
coverage required to effectively protect an implant surface against bacterial 
contamination is unknown due to lack of a suitable experimental model. Therefore, 
the aim of this study is to describe an in vitro model for post-operative bacterial 
contamination of implant surfaces and investigate the effects of different degrees of 
mammalian cell coverage on the balance between cell growth and bacterial biofilm 
formation. 
 
Materials and Methods 
 
Biomaterial surface. Poly (methyl methacrylate) (PMMA) (Vink Kunststoffen, 
Didam, The Netherlands), a commonly used biomaterial, was used as a substratum 
surface. Samples were rinsed thoroughly with ethanol (Merck, Darmstadt, Germany) 
and washed with sterile ultrapure water before use.  
 
Mammalian cell culturing and harvesting. U2OS osteosarcoma cells were routinely 
cultured in Dulbecco’s modified Eagles Medium (DMEM)-low glucose supplemented 
with 10% fetal calf serum (FBS), 0.2 mM of ascorbic acid-2-phosphate (AA2P) and 
denoted as “DMEM+FBS”. Cells were maintained at 37°C in a humidified 






Bacterial growth conditions and harvesting. S. epidermidis ATCC 35983, 
originally isolated from human blood of a patient with an infected intravascular 
catheter, was used throughout this study. First, the strain was streaked on a blood agar 
plate from a frozen stock and grown overnight at 37°C. The plate was then kept at 
4°C. For each experiment, a colony was inoculated in 10 ml of tryptone soya broth 
(TSB; OXOID, Basingstoke, England) and cultured for 24 h. This culture was used to 
inoculate a second culture, which was grown for 17 h prior to harvesting. Bacteria 
were harvested by centrifugation at 5000 x g for 5 min at 10°C and washed twice with 
sterile ultrapure water. Subsequently, the harvested bacteria were sonicated on ice (3 x 
10 s) in sterile PBS in order to break bacterial aggregates. This suspension was further 
diluted in sterile PBS to a concentration of 3 x 106 bacteria per ml. 
 
Competitive assay for mammalian cell growth and biofilm formation. The 
competitive assay was studied on the PMMA bottom plate of a parallel plate flow 
chamber (175 x 17 x 0.75 mm3), as described in detail before [9]. The flow chamber 
was equipped with heating elements and kept at 37°C throughout the experiments. 
Bacterial and U2OS cell deposition were observed with a CCD camera (Basler AG, 
Germany) mounted on a phase-contrast microscope Olympus BH-2 (Olympus, 
Germany) with a 40x objective for bacteria and 10x objective for mammalian cells. 
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, taking care to remove all air bubbles from the system. Once the system 
was filled, PBS was allowed to flow through the system at a shear rate of 11 s-1. Then, 
the U2OS cell suspension in modified culture medium, consisting of 98% 
DMEM+FBS and 2% TSB suitable for the simultaneous growth of U2OS cells and S. 
epidermidis [9], was allowed to enter the flow chamber. Once the entire volume of 
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buffer inside the chamber was replaced by the U2OS cell suspension, flow was 
stopped for 1.5 h in order to allow cells to adhere and spread on the substratum. 
Subsequently, phase contrast images (nine images, 900 x 700 µm each) were taken 
and the number of adhering cells per unit area and the area per spread cell were 
determined using Scion image software. Subsequently, modified culture medium 
supplemented with 2% HEPES was perfused through the system at a low shear rate of 
0.14 s-1 for 24 h. Experiments with three different U2OS cell densities (1.2 × 105 cells 
ml-1, 6 × 105 cells ml-1 and 13 × 105 cells ml-1) were performed to attain different 
degrees of initial cell coverage after 24 h prior to seeding of bacteria. After 24 h of 
U2OS cell growth, bacterial suspension in PBS was perfused through the chamber at 
shear rate of 11 s-1 and phase-contrast images were obtained as a function of time. As 
soon as the desired density of adhering bacteria (103 cm-2, which is a relevant number 
in implant contamination [11]), was reached (around 20 min), flow was switched to 
sterile PBS to remove unattached bacteria from the tubes and flow chamber, after 
which modified culture medium supplemented with 2% HEPES was perfused through 
the system at a low shear rate of 0.14 s-1 for another 24 h. HEPES was added in order 
to compensate for the absence of 5% CO2 during cell growth in the flow chamber.   
 
Immuno-cytochemical staining and determination of U2OS cell surface coverage. 
After simultaneous growth of bacteria and U2OS cells, surfaces were prepared for 
immuno-cytochemical staining to assess the mammalian cell morphology and 
spreading. For fixation, surfaces with adhering bacteria and U2OS cells were placed 
in a Petri dish with 30 ml of 3.7% formaldehyde in cytoskeleton stabilization buffer 
(CS; 0.1 M Pipes, 1 mM EGTA, 4% (w/v) polyethylene glycol 8000, pH 6.9). After 5 





Subsequently U2OS cells were incubated in 0.5% Triton X-100 for 3 min, rinsed with 
PBS and stained for 30 min with 5 ml PBS containing 49 µl DAPI and 2 µg ml-1 of 
TRITC-phalloidin. The cells on the surfaces were washed four times in PBS and 
examined with confocal laser scanning microscopy (CLSM, Leica DMRXE with 
confocal TCS SP2 unit). Images (nine images on different locations, 900 x 700 µm 
each) were taken and the number of adhering cells per unit area and the average area 
per spread cell were determined using Scion image software to yield the total 
coverage of the substratum surface by mammalian cells.  
 
Statistics. Data are presented as mean ± standard deviation of nine images. Statistical 
ANOVA analysis was performed followed by a Tukey’s HSD post-hoc test and a p-




U2OS cells were allowed to adhere and spread for 24 h followed by S. epidermidis 
adhesion to mimic post-operative infection. Subsequently, the simultaneous growth of 
mammalian cells and S. epidermidis was observed for 24 h.  
1.5 h after U2OS cell seeding, the average numbers of adhering U2OS cells on 
the PMMA surface were 2.5 × 104 cells cm-2, 8.2 × 104 cells cm-2 and 17 × 104 cells 
cm-2 for the different seeding densities, with an average area of the spread cells 
between 380 µm2 and 540 µm2 per cell. After 24 h of U2OS cell growth, S. 
epidermidis were allowed to adhere at a shear rate of 11 s-1 until 103 bacteria per cm2 
were counted. The adhering U2OS cells were not affected during initial adhesion of S. 
epidermidis.  
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After 24 h of simultaneous growth of U2OS cells and S. epidermidis, the 
number of adhering S. epidermidis was significantly higher (p < 0.01) on PMMA with 
the lower cell seeding density (2.5 × 104 cells cm-2 on average) as compared to the 
number of adhering S. epidermidis on PMMA with higher U2OS cell seeding 
densities. There was no significant difference in number of adhering S. epidermidis on 
PMMA with U2OS cell seeding densities of 8.2 × 104 cells cm-2 and 17 × 104 cells 
cm-2 (Fig. 1).  
 
  
Fig. 1. The number of adhering S. epidermidis ATCC 35983 after 24 h of simultaneous 
growth of bacterial and U2OS cells on PMMA with different initial numbers of U2OS cells 
present. Error bars represent the standard deviations (n = 9). * Significantly different (p < 
0.01) from the lowest U2OS cell seeding density (2.5 × 104 cells cm-2). 
 
The adhering U2OS cells were immunocyto-stained for CLSM analysis in order to 
derive their number and spread area after 48 h (Fig. 2). In Fig. 3 it can be seen, that 
the %increase in number of adhering cells was significantly reduced due to the 
presence of adhering staphylococci in all cases as compared to the control, i.e. in the 
absence of adhering staphylococci (p < 0.01) . The average area per spread cell was 





seeding density of 17 × 104 cells cm-2, U2OS cells spread to only 460 µm2 per cell, 
similar to control (Fig. 4).  
 
 
Fig. 2. CLSM images of U2OS cells seeded to a density of (a) 2.5 × 104 cells cm-2, (b) 8.2 × 
104 cells cm-2 and (c) 17 × 104 cells cm-2 after 48 h of growth in the presence of adhering S. 
epidermidis ATCC 35983 on PMMA. U2OS cells were stained with 5 ml PBS containing 49 
µl DAPI and 2 µg ml-1 of TRITC-phalloidin. The bars denote 75 µm. 
 
 
Fig. 3. Percentage increase in the number of adhering U2OS cells after 48 h of growth with 
respect to their initial number immediately after seeding at 1.5 h on PMMA in the absence (□) 
and presence (■) of adhering S. epidermidis ATCC 35983. Error bars represent the standard 
deviations (n = 9). *Significantly different (p < 0.01) from the lowest U2OS cell seeding 
density (2.5 × 104 cells cm-2).  
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In the concept of the race for the surface, the total cell surface coverage of the 
substratum by host tissue cells is determinant for the fate of an implant. The surface 
coverage of U2OS cells at 1.5 h after seeding and after 48 h of growth are shown in 
Fig. 5. After 1.5 h of U2OS cell seeding, the average surface coverages by U2OS cells 
on PMMA surface were 12%, 33% and 65% for seeding densities 2.5 × 104 cells cm-2, 
8.2 × 104 cells cm-2 and 17 × 104 cells cm-2, respectively. After 24 h of U2OS cell 
growth, a slight increase of 5% - 10% in surface coverage was observed (data not 
shown). After 48 h of growth in the absence of S. epidermidis, a significant increase 
(p < 0.01) in surface coverage by adhering cells was observed compared to 1.5 h. In 
the presence of S. epidermidis, a significant reduction (p < 0.01) in surface coverage 
by adhering cells was observed at the lowest cell density (2.5 × 104 cells cm-2) as 
compared to the control, i.e. in the absence of adhering staphylococci. At the higher 
cell densities, cell surface coverage was similar in the absence or presence of adhering 
staphylococci.  
  
Fig. 4. Average area per adhering U2OS cells immediately after seeding at 1.5 h (□) and after 
48 h (■) of growth on PMMA in the absence and presence of adhering S. epidermidis ATCC 
35983. Error bars represent the standard deviations (n = 9). *Significantly different (p < 0.05) 







Fig. 5. Surface coverage by adhering U2OS cells immediately after seeding at 1.5 h (□) and 
48 h (■) of growth on PMMA in the absence and presence of adhering S. epidermidis ATCC 
35983. Error bars represent the standard deviations (n = 9). *Significantly different (p < 0.01) 




This paper presents the first experimental in vitro study on the race between bacteria 
and tissue cells on PMMA in a post-operative bacterial contamination model of 
implant surfaces. Below a threshold coverage of the substratum surface by adhering 
mammalian cells, contaminating S. epidermidis ATCC 35983 negatively impacted 
mammalian cell growth, but once cell surface coverage exceeded a critical value, 
contaminating S. epidermidis ceased to negatively impact cell growth. The bacterial 
challenge chosen in the current experiments was low and is similar to peri-operative 
contamination levels [11,12]. Kaduragamuwa et al. [11] showed in a murine model 
that low doses of bacteria, introduced either peri-operatively or post-operatively, 
established a stable infection resembling the clinical situations. Therefore, the 
bacterial challenge concentration used is considered relevant.  
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The current study was conducted with S. epidermidis. Clinically, S. 
epidermidis is one of the main causative organisms for BAI in particular chronic 
prosthetic joint infections [13,14]. S. epidermidis can yield early post-operative 
contamination as long as wound closure is incomplete. Alternatively, late 
haematogenous spreading may occur from infections elsewhere in the body to an 
implant surface. Notorious in this aspect are abscesses underneath the skin, 
developing for instance after minor injuries. Also dental treatment is known to be a 
cause of post-operative contamination of implant surfaces, as even routine inspection 
of the dentition by a dentist or mouth hygienist may give rise to bacteraemia [15,16]. 
BAI due to S. epidermidis is usually low grade, since the organism lacks the genes to 
produce toxins and tissue damaging exoenzymes, that are produced by, for instance 
Staphylococcus aureus [17,18], another causative strain of BAI [13,14]. S. aureus 
infections are therefore more aggressive than S. epidermidis ones, but at the same time 
are more readily noticed and treated. In a sense this makes the low-grade BAI due to 
S. epidermidis more troublesome, which motivates our current choice for S. 
epidermidis to set up our post-operative contamination model.  
PMMA is well-know for its use in ophthalmological, orthopedic and dental 
applications. In orthopedic applications, PMMA-based bone cements are extensively 
used for fixation of total joint replacements, as the material supports cell adhesion and 
spreading [19-21]. In a peri-operative contamination model, PMMA showed better 
tissue cell adhesion and spreading in the presence of adhering S. epidermidis than 
other commonly used biomaterials [10].  
In the concept of the race for the surface, complete surface coverage of a 
biomaterial in vivo by viable tissue cells, combined with functional host defense 





and complete surface coverage of mammalian cells restricts the biomaterial surface 
area available for bacterial adhesion and biofilm formation. Dexter et al. [22] 
suggested that an optimal concentration of seeded 3T3 fibroblasts and conditions to 
stimulate cell adhesion and surface coverage without stimulating bacterial adhesion 
could probably reduce infection. However, the consequence of the combined presence 
of mammalian cells and bacteria on a surface was not monitored. In this study, the 
presence of S. epidermidis ATCC 35983 showed negative effects on cell surface 
coverage by U2OS cells at the lowest initial cell density (2.5 × 104 cells cm-2) as 
compared to cell surface coverage in the absence of adhering staphylococci. In 
contrast, surface coverage of U2OS cells after seeding higher initial cell densities was 
not influenced by the presence of S. epidermidis. Therewith this study provides direct 
experimental evidence for the Gristina postulate [8] that in vivo tissue integration 
protects implant surfaces against bacterial colonization. Moreover, our study defines a 
critical cell surface coverage needed in order to protect an implant surface against S. 
epidermidis biofilm formation. We anticipate that this critical cell surface coverage 
level will depend on the biomaterial surface characteristics as well as on the infecting 
strain. With this model system we present a tool to assess the ‘race for the surface’ 




An in vitro method is presented to study the effects of post-operative bacterial 
contamination on the interaction of mammalian cells with biomaterial implants. A 
critical mammalian cell surface coverage was found, above which contaminating S. 
epidermidis ATCC 35983 no longer had a negative impact on mammalian cell 
growth. Thus following the concept of the race for successful implantation of a 
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biomaterial, survival of the implant will be more solidly assured if an implant is 
rapidly integrated by tissue to above this critical cell surface coverage. This new 
method and the concept of critical cell surface coverage will allow better evaluation of 
biomaterial coatings prior to animal experiments or human trials, than based on 
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Biomaterial-associated infections (BAI) are a widespread complication that threatens 
the longevity and functionality of indwelling biomaterial implants and devices and the 
consequences in terms of medical care are severe. Despite of improved techniques and 
highly sterile conditions in the operating theatre, peri-operative contamination by 
microorganisms suspended in the air and from the skin flora continues to be the most 
common pathway for the contamination of biomaterial implants and devices [1,2].  
Staphylococcus aureus and Staphylococcus epidermidis are microorganisms 
frequently isolated from BAI. S. epidermidis is found in almost 50% of the infections 
associated with catheters, artificial joints and heart valves, while S. aureus is seen in 
around 23% of the infections associated with prosthetic joints [3]. These commensals 
from the skin adhere to the biomaterial surface and grow to form a biofilm. Bacteria 
in their biofilm mode of growth are frequently more resistant to antibiotic treatment 
and the host immune system than their planktonic counterparts. Hence, removal of an 
infected implant or device is often the only remedy for a BAI. Surrounding tissue, 
however, may remain compromised by bacterial presence for prolonged periods of 
time after removal of the biomaterial [4,5] which severely lowers the prospects of a 
secondary implant or device, since bacteria in tissue constitute a new source for BAI 
to develop. 
Whether or not BAI will occur, ultimately depends on the interaction between 
the biomaterial, the bacterium involved and host cells. Host cells and bacteria battle to 
proliferate and colonize a biomaterial surface. The general assumption is that on 
surfaces with a high affinity for tissue cells, bacterial biofilm formation will be 





faster than tissue cells, bacterial toxins and virulence factors can impair cell functions 
leading to  BAI [6].  
In a healthy host, the host immune system comes to the aid of tissue cells [7]. 
Macrophages are one of the most predominant immune cells that arrive within 
minutes to hours at an implant site and can remain at a biomaterial surface for several 
weeks to orchestrate the inflammation process and eventually foreign body reactions 
[7]. During infection, macrophages detect bacteria via cell surface receptors that bind 
to bacterial ligands and opsonines [8]. Subsequently, macrophages ingest pathogens 
and activate cellular functions such as proliferation, secretion of proteins and 
cytokines, and respiratory burst to destroy phagocyted microorganisms and recruit 
other cells from the adaptive immune system [9]. However, it has been shown that the 
presence of a foreign body may impair the host immune system and very low numbers 
of adherent bacteria are already sufficient to create a BAI [6]. 
Currently, biomaterials research is strongly focused on the design of novel 
functional coatings that reduce the risk of BAI by inhibiting bacterial adhesion and 
stimulating tissue cell adhesion [10,11]. However, in the evaluation of these coatings, 
bacterial and tissue cell adhesion are often considered as independent phenomena and 
not as simultaneous events [10,11]. Furthermore, the response of the immune system 
to bacterial colonization on these coatings is generally ignored. Recently, a novel in 
vitro method has been forwarded to determine the influence of bacterial presence on 
the outcome of the competition between bacteria and tissue cells in their attempt to 
colonize or integrate a biomaterial surface [12].  
In this study we present an extension of this model [12] to include also the 
influence of macrophages on the outcome of the race for the surface between adhering 





Materials and Methods 
 
Biomaterial. Poly (methyl methacrylate) (PMMA) (Vink Kunststoffen, Didam, The 
Netherlands) was used as a substratum. Samples were rinsed thoroughly with 70% 
ethanol (Merck, Darmstadt, Germany) and washed with sterile ultrapure water before 
use. Water contact angles on thus cleaned PMMA were 73 ± 3 degrees, in line with 
literature [13].  
 
Tissue cell culturing and harvesting. U2OS osteosarcoma cells were routinely 
cultured in Dulbecco’s modified Eagles Medium (DMEM)-low glucose supplemented 
with 10% fetal calf serum (FBS, non-heat inactivated), 0.2 mM of ascorbic acid-2-
phosphate (AA2P). Cells were maintained at 37°C in a humidified atmosphere with 
5% CO2, and passaged at 70 – 90% confluency using trypsin/EDTA.  
 
Macrophages culturing and harvesting. J774 murine macrophages were routinely 
cultured in Dulbecco’s modified Eagles Medium (DMEM)-high glucose 
supplemented with 10% fetal calf serum (FBS, non-heat inactivated) and denoted in 
the paper as “optimal medium”. Macrophages were maintained at 37°C in a 
humidified atmosphere with 5% CO2, and passaged at 70 – 80% confluency by 
scraping.  
 
Bacterial growth conditions and harvesting. The bacterial strains used in this study 
were S. epidermidis ATCC 35983 and S. aureus ATCC 12600. These strains were 
cultured on blood agar plates and grown aerobically overnight at 37°C, and the plates 
were kept at 4°C, never longer than two weeks. For each experiment, one colony was 





and incubated for 24 h at 37°C in ambient air. This culture was used to inoculate 
another culture in 200 ml TSB that was incubated overnight at 37°C prior to 
harvesting. Bacteria were harvested by centrifugation (5 min at 5000 g at 10°C) and 
washed twice with sterile ultrapure water. Bacteria were sonicated intermittently on 
ice (30 s) in sterile phosphate buffered saline (PBS, 10 mM potassium phosphate, 150 
mM NaCl, pH 6.8) to break bacterial aggregates, and resuspended in 200 ml sterile 
PBS to a concentration of 3 x 106 bacteria per ml. Prior to the experiments, growth 
and biofilm formation of S. epidermidis ATCC 35983 and S. aureus ATCC 12600 in 
optimal medium was confirmed by culturing bacteria in optimal medium for 24 h. 
 
In vitro multiple cell type culture assays. The competition between bacteria and 
U2OS cells for the colonization of PMMA in the absence of macrophages (control) 
and in the presence of macrophages was assessed under laminar flow on the bottom 
plate of a parallel plate flow chamber (175 x 17 x 0.75 mm3). Bacterial and cell 
deposition were observed real-time using a CCD camera (Basler AG, Germany) 
mounted on a phase-contrast microscope Olympus BH-2 (Olympus, Germany). The 
flow chamber was equipped with heating elements and kept at 37°C throughout the 
experiments.  
Prior to each experiment, all tubes and the flow chamber were filled with 
sterile PBS, taking care to remove all air bubbles from the system. Once the system 
was filled, and before the addition of bacterial suspension, PBS was allowed to flow 
through the system at a shear rate of 11 s-1. Then, a bacterial suspension in PBS was 
perfused through the chamber at the same shear rate and phase-contrast images were 
obtained. As soon as the desired density of adhering bacteria (103 cm-2), was reached, 





suspension from the tubes and chamber. Subsequently, a cell suspension consisting of 
U2OS cells (6 × 105 cells ml-1) and J774 macrophages (12 × 105 cells ml-1) in 
optimum medium was added to the flow chamber. Once the entire volume of buffer 
inside the chamber was replaced by the cell suspension, flow was stopped for 1.5 h in 
order to allow U2OS cells and macrophages to adhere and spread on the substratum 
surface. Ultimately, “optimum medium” supplemented with 2% HEPES was perfused 
through the system without recirculation at a shear rate of 0.14 s-1 for 24 h and phase-
contrast images were obtained continuously at 2 min intervals. Biofilm growth was 
assessed in real-time by determining the numbers of adhering bacteria per unit area 
using proprietary software based on the Matlab Image processing Toolkit (The 
MathWorks, MA, USA). 
At the end of the assay, surfaces were prepared for qualitative analysis to 
assess U2OS cell and macrophages morphology and spreading. Cells adhering to 
PMMA were fixed with citrated-acetone-formaldehyde fixative solution for 30 s and 
stained with an alkaline-dye mixture (Sigma-Aldrich, Germany) (Naphtol AS-BI 
phosphate, sodium nitrite, fast blue BB base) for 15 min. The samples were 
subsequently rinsed with demineralized water and counterstained for 2 min with 
neutral red solution. Then the samples were rinsed once again with demineralized 
water, allowed to dry and phase-contrast images were taken on different places of the 
sample. Differentiated U2OS osteosarcoma cells stained purple/blue (alkaline 




Bacteria were allowed to adhere to the biomaterial surface prior to U2OS cell and 





U2OS cells and macrophages were allowed to grow simultaneously for 24 h. Events 
are illustrated as follows. 
 
Migration of macrophages towards bacteria and phagocytosis. The number of 
bacteria adhering to the PMMA surface prior to U2OS cells and macrophages 
adhesion was set to 103 cm-2, using the image analysis system Subsequently, U2OS 
cells and macrophages were allowed to adhere to the surface and the simultaneous 
interactions of bacteria, macrophages and U2OS cells were observed by phase-
contrast microscopy. Figure 1 shows macrophage migration in the presence of U2OS 
cells towards adhering bacteria and subsequent phagocytosis. Macrophage migration 
towards bacteria and phagocytosis was similar on PMMA colonized by S. epidermidis 
and S. aureus.  
 
 
Fig. 1. Phase-contrast images of macrophage activity toward S. epidermidis ATCC 35983 on 
a PMMA surface in the presence of U2OS cells: macrophage migration towards S. 
epidermidis (images 1-5), bacterial clearance by phagocytosis (images 6-7) and further 






Bacterial biofilm formation in the absence and presence of macrophages. Biofilm 
growth was assessed over time by determining the numbers of bacteria adhering to 
PMMA at different time points during the simultaneous growth of bacteria, U2OS 
cells and macrophages (Fig. 2). In the presence of macrophages, reduction in the 
numbers of adherent bacteria, both for S. epidermidis and S. aureus, was observed as 
compared to controls (absence of macrophages). This effect was observed up to 20 h 
of growth for S. epidermidis and up to 14 h for S. aureus. Thereafter macrophage 
burst and release of ingested bacteria was observed. 
 
  
Fig. 2. The numbers of adhering bacteria on PMMA as a function of time during the 
simultaneous growth of bacteria and U2OS cells in the absence and presence of macrophages 
in a parallel plate flow chamber (shear rate 0.14 s-1).  
S. epidermidis in the absence of macrophages (□), S. aureus in the absence of macrophages 
(○), S. epidermidis in the presence of macrophages (■) and, S. aureus in the presence of 
macrophages (●). 
 
Bacterial-tissue cell interactions in the absence and presence of macrophages. 
Immediately after seeding, U2OS cell adhesion and spreading on PMMA was 
observed independently of whether macrophages were present or not. After 24 h of 





biofilm irrespective of the absence or presence of macrophages. On the other hand, 
colonizing S. epidermidis did not significantly affect U2OS cells and their adhesion 




Fig. 3. Phase-contrast images of adhered cells to PMMA after 24 h of simultaneous growth of 
U2OS and S. epidermidis ATCC 35983 or S. aureus ATCC 12600 in the absence (upper 
images) and presence (lower images) of macrophages. Macrophages are orange-stained. The 




This paper presents the first experimental model to study the simultaneous interaction 
of macrophages-bacteria-osteoblasts on a biomaterial surface in a single experiment. 
In our in vitro model, bacteria were allowed to adhere prior to adhesion of 
macrophages and U2OS cells, which mimics a peri-operative bacterial contamination 
of implant surfaces. The number of bacteria adhering on the PMMA surface prior to 





documented that during a surgical procedure of 1 h, the total number of bacteria 
carrying particles falling on a wound is about 270 cm-2. The bacterial counts were 
generally higher during periods of high activity and when more people were present in 
the operation theatre [14]. Recently, through the use of modern, better ventilated 
operation theatres (20 changes of air/h) and impermeable patient and personnel 
clothing, peri-operative bacterial contamination is likely to be reduced [15]. However, 
many surgical procedures in which implants are introduced in the body last longer 
than 1 h. Therefore, the level of bacterial contamination chosen in our experiments is 
probably realistic of a worst case scenario. Despite these low numbers, peri-
operatively introduced organisms, particularly when of low virulence, can survive on 
an implant surface for prolonged periods of time and later, during periods of host 
immune depression, they proliferate and establish an infection with clinical symptoms 
[16].  
The pathogenesis of BAI is complex and depends on factors such as bacterial 
virulence, physicochemical properties of the biomaterial and alterations in the host 
defense [17]. Previously, in our model for the competition between bacteria and tissue 
cells, all common biomaterial surfaces, including PMMA, allowed S. epidermidis 
ATCC 35983 biofilm formation with a negative impact on the coverage of the 
biomaterial surface by tissue cells [13]. Yet, PMMA showed better cell adhesion and 
spreading in the presence of adhering S. epidermidis ATCC 35983 than other 
commonly used biomaterials [13]. Our present study supports our previous 
observations that U2OS cells are able to adhere, spread and grow in the presence of S. 
epidermidis ATCC 35983, and extend these observations to the absence and presence 
of macrophages. On the other hand, in the presence of adhering S. aureus ATCC 





despite the suspected removal of the majority of the bacterial toxins by flow. These 
observations are in line with clinical findings that BAI due to S. aureus usually 
progresses much more aggressively than BAI caused by S. epidermidis. In S. 
epidermidis infections, biofilm formation is considered the only virulence factor and 
therefore infections are usually sub-acute or chronic. The low virulence of S. 
epidermidis strains compared to S. aureus is due to the lack of additional genes 
responsible for producing severely tissue damaging toxins [3,18].  
In general, immune cells migrate, engulf and kill invading microorganisms 
[19-21]. A previous study on the interaction between macrophages and colonizing S. 
epidermidis, showed that macrophage behavior is surface dependent [22]. 
Macrophage migration towards bacteria and phagocytosis was enhanced on cross-
linked poly(ethylene)-glycol (PEG) based polymer coatings compared to the uncoated 
substrata due to the weak adhesion of macrophages and bacteria to the PEG coating 
[22]. In our study, macrophages migrate towards the bacteria on a PMMA surface and 
engulfed the bacteria. The phagocytosis of bacteria by macrophages differs depending 
on the virulence of the strain. In the presence of low virulent S. epidermidis, bacterial 
biofilm growth was strictly reduced by the presence of macrophages up to 20 h 
compared to only 14 h in the case of high virulent S. aureus biofilm growth. These 
results are in line with previous studies showing that in both in vivo and in vitro the 
uptake rate of bacteria by macrophages was inversely proportional to the virulence of 
the bacteria [23,24]. Furthermore, macrophages disintegration and necrotic death has 
been observed in vitro and in vivo due to overloading with ingested bacteria [25,26]. 
In this study it was observed that after a period of time macrophages become 
exhausted and break open which leads to a burst release of bacteria. At least part of 





J774 macrophages in this model are not able to kill all phagocytised bacteria. 
Although the viability of the released bacteria was not assessed, several studies have 
demonstrated that immune cells lose their ability to kill bacteria [25,21,27,28]. Leid et 
al. [29] showed that leukocytes were able to migrate to S. aureus biofilms but failed to 
phagocyte the bacteria. Neutrophils adjacent to Teflon cages, implanted in peritoneal 
cavities, exhibited decreased bactericidal activity and reduced superoxide production 
due to the increased production of S. epidermidis extracellular slime [30-33]. 
Watanabe et al. [28] demonstrated that engulfed S. aureus suppressed the production 
of superoxide, resulting in the prolonged survival inside the macrophages. In a murine 
model it was shown that high numbers of S. epidermidis could persist within 
macrophages in peri-catheter tissue without showing any signs of inflammation [17]. 
Also S. epidermidis inside macrophages were not only viable but were able to 
proliferate. In vivo, the local host defense was compromised because of the presence 
of biomaterials, resulting in deficient intracellular killing of pathogens by 
macrophages [17]. 
The influence of macrophages on the competition between bacteria and 
mammalian cells is novel. This study demonstrates that despite the presence of 
macrophages, mammalian cells lost the race for the surface in the presence of high 
virulent S. aureus. In vivo, bacteria may well survive inside the macrophages for 
prolonged periods of time. These bacterial will favor the development of BAI, 
especially when certain physical conditions of the patients disturb the balance 
between bacteria and the host response [17]. This model validated for bacteria-
macrophages-osteoblasts interactions in a flow chamber system resembles the in vivo 
environment more closely than single-cell type cultures therewith providing an 





qualitatively analyzed, we believe that this methodology supported with quantitative 
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Hitherto, biomaterials or functional coatings for application in dentistry or orthopedics 
addressing infections are evaluated in vitro either for their ability to resist bacterial 
adhesion and biofilm formation or for their ability to enhance mammalian cell 
adhesion and proliferation [1-6]. However, according to Anthony Gristina, in vivo the 
fate of a biomaterial implant can be depicted as a race between microbial adhesion 
and biofilm formation on the implant surface versus tissue integration [7]. Even 
though the concept of the race for the surface has been embraced by many researchers 
in the field, unfortunately there has been no in vitro methodology forwarded to study 
the actual race. In vivo, the processes occurring at a biomaterial surface are quite 
complicated and involve multiple cell types, cytokines, chemokines, and secretion of 
bacterial and cellular substances [8]. These processes are difficult to adequately 
address with current in vitro models, but in vitro experiments are indispensable in 
order to develop new functional materials and coatings. Moreover, well designed and 
predictive in vitro experiments are often a requirement in order to obtain approval for 
animal experiments and at the same time reduce the need for animal experiments.  
Therefore, the goal of the studies described in this thesis was to bridge the gap 
between the in vitro and in vivo evaluation of biomaterials-associated infections.  
 
Bacterial Biofilm Growth versus Mammalian Cell Growth 
 
As a first step, we developed a methodology to conduct the competition between 
bacteria and mammalian cells on the biomaterial surface. The development of 
methodologies were based on the two infection models: peri-operative and post-
operative contamination of biomaterial implants. In the methodology based on peri-





to a biomaterial surface prior to U2OS osteosarcoma cell adhesion and spreading to 
mimic the clinical situation where an implant becomes contaminated prior to 
implantation. We observed that the U2OS cells lost the competition in the absence of 
flow due to the accumulation of bacterial toxins, but were able to grow under flow 
due to continuous supply of fresh medium and remove the bacterial toxins from the 
interface. In vivo fluid flows continuously through the net-work of fine channels of 
osteocytes to facilitate the diffusion of nutrients and waste products [9]. In the concept 
of the race for the surface, tissue integration is an important protective factor against 
bacterial contamination of an implant surface [7]. Therefore, another methodology 
was developed based on post-operative contamination to investigate the effects of 
different degrees of mammalian cell coverage on the balance between bacterial 
biofilm formation and mammalian cell growth. We observed that mammalian cell 
growth was severely impaired when bacteria were introduced on surfaces with a low 
initial mammalian cell density (2.5 × 104 cells cm-2) but in the presence of higher 
initial cell densities (8.2 × 104 cells cm-2 and 17 × 104 cells cm-2), contaminating 
staphylococci did not affect cell growth. 
Results suggest that the methodologies based on these two infection models 
could be well used in the evaluation of biomaterials infections, resembling the in vivo 
situation more closely than traditional single cell type cultures.  
 
Evaluation of Biomaterials  
 
Biomaterials can be broadly classified into two main categories biopassive and 
bioactive. Biopassive materials cannot induce any interfacial biological bond between 
implants and host cells. Metallic materials such as cobalt-chromium-molybdenum 






alloys and titanium-aluminium-vanadium alloys are used in hip replacements [10] and 
polymeric materials such as poly (methyl methacrylate) (PMMA), 
(hydroxyethylmethacrylate), polyethylene oxide (PEO), phosphoryl choline are used 
in the field of ophthalmology (i.e contact lenses, intraocular lenses, keratoprosthesis 
optics and vitreous substitutes) [11] are some examples of biopassive materials. None 
of the synthetic materials are truly inert but materials like phosphoryl choline and 
polyethylene oxide are considerably promising in down-regulating biological 
responses in ophthalmology [11]. 
Bioactive materials can attach directly with body tissues and form chemical 
and biological bonds during the early stages of the post implantation period. Materials 
such as tricalcium phosphates, hydroxyapatites and calcium sulphate are some 
examples of bioactive materials [10]. Materials like tricalcium phosphates are 
osteoconductive because osteoblasts adhere and deposit bony tissue on the surface. 
Current efforts are being directed towards distilling the essence of cell adhesion 
requirements in new biomaterials incorporating minimal peptide sequences from 
adhesion molecules responsible for integrin binding. Biomaterials incorporated with 
RGD (arginine-glycine-aspartic acid) enhances tissue integration [11].  
Based on the Gristina’s ‘race for the surface’, the competition between S. 
epidermidis ATCC 35983 and U2OS cells on different biomaterials showed that 
mammalian cell interactions with biomaterials were hampered by bacterial biofilm 
formation on all biomaterials used. Yet, PMMA showed better U2OS cell adhesion 
and spreading in the presence of S. epidermidis compared to other biomaterials 
(Chapter 3). This study suggest that the race for the surface depends on the physico-
chemical properties of the biomaterial surface and on the density of contaminating 





RGD) showed better cell adhesion and spreading and cells were less affected by the 
presence of S. epidermidis ATCC 35983 compared to mono-functional coatings 
(biopassive PLL-g-PEG) and bare titanium oxide surfaces (Chapter 5).  
 
Bacterial Strain-Specific Effects on the Competition Between 
Bacterial Biofilm Growth versus Mammalian Cell Growth 
 
Many different pathogens such as S. epidermidis, Staphylococcus aureus, Escherichia 
coli and Pseudomonas aeruginosa can be isolated from infected biomaterial implant 
surfaces, depending on their body site [7,8,12]. After an initial focus on S. 
epidermidis, our study on the competition between bacteria and mammalian cells was 
extended to different bacterial strains. We observed U2OS cell death within 18 h of 
simultaneous growth of S. aureus or P. aeruginosa and U2OS cells despite removal of 
bacterial toxins by flow, whereas U2OS cells were able to adhere, spread and grow in 
the presence of S. epidermidis. These observations are inline with the clinical findings 
that BAI due to highly virulent S. aureus and P. aeruginosa usually progresses much 
more aggressively than BAI caused by low virulent S. epidermidis. This study 
highlights the importance of bacterial virulence as a factor in the pathogenesis of BAI. 
However, characterization and quantification of substances released by bacteria was 
not performed. Hence, exact parameters responsible for mammalian cell death were 
unknown. However, studies showed that in S. aureus, most extracellular and surface 
attached virulence factors are regulated by the agr (accessory gene regulator) locus, a 
quorum-sensing system and the expression of agr-regulated targets is bacterial cell 
density-dependent. With increase in bacterial cell density agr becomes active, and 
starts producing extracellular degradative exoenzymes and toxins [13,15]. A similar 
cell-to-cell signalling (quorum-sensing) system plays a major role in the P. 






aeruginosa virulence factors [14]. In contrast to S. aureus and P. aeruginosa, S. 
epidermidis produce a very limited number of tissue damaging exoenzymes and 
toxins. The only toxin made by S. epidermidis is N-formylated alpha-helical peptide 
-toxin, which plays a major role in the construction of a structured biofilm and in the 
detachment from surfaces [15].  
 
Limitations of the In Vitro Experimental Model 
 
In our experiments, we have focused on the development of in vitro methodology for 
the evaluation of new functional biomaterials and coatings to prevent biomaterial-
associated infection. Our in vitro results are inline with clinical findings and provide 
additional information prior to animal experiments than in vitro studies addressing 
solely bacterial or tissue cell responses to biomaterials. However, the bacterial 
phenotypic changes occurring in vivo, resistance against antibiotics and host immune 
system are not taken into account in our in vitro model, which constitutes a major 
limitation. Secondly, the mechanism of interaction between host and biomaterial 
implant cannot be studied. Nevertheless, the evaluation of biomaterials based on these 
methodologies provides more information than can be obtained based on traditional in 




The model provided here to study the race for the surface methodologies shows that 
biomaterials contaminated even with very low number of bacteria can ultimately 
harvest a biofilm capable of influencing mammalian cell adhesion and growth 





need for development of biomaterials or coatings with selective toxicity to bacteria 
and only stimulating mammalian cell adhesion and growth. 
It would be interesting to answer research questions such as: i) What would be 
the outcome of the race for the surface if both bacteria and mammalian cells are 
introduced to the biomaterial surface at the same time? ii) Could a biomaterial surface 
completely covered by a monolayer of mammalian cells prevent bacterial 
colonization? ii) What would be the outcome of the race for the surface if the 
biomaterial surface is pre-treated with physiologically relevant proteins? 
Future experiments also includes characterization and quantification of the 
substances released by bacteria prior to the race for the surface study in order to gain a 
better insight on the influence of bacteria on mammalian cells adhesion and growth. 
This in vitro methodology could be progressed towards resembling the in vivo 
environment quite closely by incorporating antibiotics, growth factors and cytokines. 
Furthermore, animal experiments should be performed in order to validate the in vitro 
model, but pre-screening materials and coatings with the methodology developed here 
may save a large number of animals.  
The choice of cell type in this thesis was mainly focussed on the orthopedic 
applications, but this methodology could be applicable for other cell types and implant 
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Biomaterial-associated infections (BAI) are the major cause of implant failure and can 
develop many years after implantation. BAI can develop from peri-operative 
microbial contamination of implant surfaces during implantation, immediately post-
surgery during hospitalization or by late hematogenous spreading from infections 
elsewhere in the body. The microorganisms involved in BAI are resistant to 
antibiotics due to their biofilm mode of growth and the infected implant has to be 
removed in most cases. 
In 1987, the orthopedic surgeon Anthony G. Gristina coined the term “the race 
for the surface” to describe the fate of biomaterial implants in relation with the 
development of BAI. The fate of a biomaterial implant was depicted as a race between 
microbial adhesion and biofilm growth on an implant surface versus tissue 
integration. If the race is won by tissue cells, then the surface is covered by tissue and 
less vulnerable to bacterial colonization. On the other hand, if the race is won by 
bacteria the implant surface will become rapidly covered by a biofilm and tissue cell 
functions will be hampered by bacterial virulence factors and toxins. The concept of 
race for the surface has been embraced by many researchers in this field, but hitherto 
there has been no in vitro methodology forwarded to study the race. 
Chapter 1 reviews the main causes of implant failure and development of 
BAI. Irrespective of the route of infection, the fate of a biomaterial implant depends 
mainly on the outcome of the so-called “race for the surface”. In the past till now, 
researchers predicted the outcome of the race for the surface by in vitro evaluation of 
biomaterials or functional coatings either for their ability to resist bacterial adhesion 
and biofilm formation or for their ability to support mammalian cell adhesion and 
proliferation. However, the effects of the presence of bacteria including the influence 
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unknown, which could completely change the fate of a biomaterial implant according 
to the concept of the “race for the biomaterial surface”. Therefore, the main aim of 
this thesis is to develop a method that could bridge the gap between in vitro and in 
vivo studies on BAI. 
Chapter 2, as a first step towards bridging the gap between in vitro and in 
vivo studies, an in vitro experimental methodology was developed based on Anthony 
G. Gristina‘s concept of the “race for the surface”. This methodology was developed 
based on the peri-operative contamination model in which the implant becomes 
contaminated prior to implantation. After developing a suitable growth medium that 
allowed both bacterial and mammalian cell growth in the parallel plate flow chamber, 
the simultaneous growth of Staphylococcus epidermidis ATCC 35983 and U2OS 
osteosarcoma cells was studied for a period of 48 h. The outcome of the competition 
between S. epidermidis ATCC 35983 and U2OS cells appeared to be dependent on 
the number of bacteria present prior to U2OS cell seeding and the absence or presence 
of fluid flow. U2OS cells lost the competition in the absence of flow, probably due to 
the accumulation of bacterial toxins, but were able to grow under flow due to the 
continuous supply of fresh medium and removal of most endotoxins from the 
interface.  
This methodology based on the peri-operative contamination model was used 
to determine the influence of biomaterial surfaces with different wettabilities and a 
polymer brush coating on the outcome of the competition between S. epidermidis 
ATCC 35983 and U2OS cells which is described in chapter 3. This study 
demonstrated that the presence of S. epidermidis reduced U2OS cell growth on all 
surfaces, but adhering U2OS cell spread equally well in the absence and presence of 





adhesion and growth. This study highlights the non existence of a surface on which 
the race for the surface can be won by mammalian cells and therefore emphasizes the 
need for biofunctionalized surfaces that discourage biofilm formation and support 
mammalian cell growth at the same time.  
There are different pathogens involved in BAI, such as S. epidermidis, 
Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. It is known 
that bacterial virulence is a contributing factor in pathogenesis of BAI. In chapter 4, 
the influence of different strains of S. epidermidis, S. aureus and P. aeruginosa on the 
outcome of the competition between bacteria and mammalian cells for the biomaterial 
surface was studied. U2OS cells are able to adhere, spread and grow in the presence 
of adhering S. epidermidis strains but not in the presence of adhering S. aureus or P. 
aeruginosa, which cause death of all adhering U2OS cells within 18 h, despite the 
continuous medium flow. These observations are in line with clinical findings that 
BAI due to S. aureus and P. aeruginosa usually progress much more aggressively 
than BAI caused by S. epidermidis. This study highlights the potential of this in vitro 
model to be used to investigate the effect of pathogen virulence on host tissue cells in 
BAI. 
In chapter 5, bacterial and cellular responses to poly(ethylene glycol) (PEG) 
brush coatings on titanium oxide surfaces presenting the integrin-binding peptide 
RGD (arginine-glycine-aspartic acid) (bioactive “PEG-RGD”) were compared to 
mono-functional PEG brush coatings (biopassive “PEG”) and bare titanium oxide 
(TiO2) under flow. In this chapter, bacteria were allowed to adhere for a fixed period 
of 2 h on all surfaces prior to mammalian cell adhesion and spreading and 
simultaneous growth of bacteria and mammalian cells was allowed for a period of 48 
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PEG-RGD coatings, compared to the TiO2 surface. When allowed to grow for 48 h, 
biofilms were formed on all surfaces. However, biofilms on PEG and PEG-RGD 
coatings detached when exposed to higher shear. U2OS cells neither adhered nor 
spread on the biopassive mono-functional coating PEG regardless of the presence of 
biofilm. In contrast, in the presence of biofilm, U2OS cells adhered and spread on the 
bioactive PEG-RGD coating with a significantly higher surface coverage than on bare 
TiO2. This study highlights the potential of bifunctional coatings to reduce the risk of 
infection in the applications requiring tissue integration.  
In the concept of the race for the surface, as forwarded by the late orthopedic 
surgeon Gristina, tissue integration is an important protective factor against bacterial 
contamination of an implant surface. Therefore, chapter 6 was focused on the 
development of an in vitro model based on post-operative bacterial contamination of 
implant surfaces. The effect of differences in mammalian cell coverage on the balance 
between mammalian cell growth and bacterial biofilm formation was investigated. In 
this study, mammalian cells were allowed to adhere and spread for 24 h followed by 
S. epidermidis adhesion to mimic post-operative infection. Subsequently, the 
simultaneous growth of mammalian cells and S. epidermidis was observed for another 
24 h under low shear conditions (0.14 s-1). Mammalian cell growth was severely 
impaired when bacteria were introduced on surfaces with a low initial cell density (2.5 
× 104 cells cm-2), but in the presence of higher initial cell densities (8.2 × 104 cells cm-
2 and 17 × 104 cells cm-2), contaminating staphylococci did not affect cell growth. A 
critical mammalian cell coverage (8.2 × 104 cells cm-2) was determined, above which 
the contaminating S. epidermidis ATCC 35983 no longer had a negative impact on 





is needed to effectively protect a biomaterial implant against contaminating S. 
epidermidis. 
The success of an implant is a complex interplay between factors such as 
physico-chemical properties of the biomaterial surface, bacterial virulence and 
alteration in the immune system. As a second step in bridging the gap between in vitro 
and in vivo studies, the influence of immune cells (macrophages) on the competition 
between bacteria and mammalian cells was studied in chapter 7. This study based on 
the peri-operative contamination model validates the interactions of multiple cell 
types (bacteria-macrophages-osteoblast cells) which more closely resembles the in 
vivo environment than single cell type cultures. Results showed that despite the 
presence of macrophages, mammalian cells lost the race for the surface in the 
presence of the highly virulent S. aureus.  
In the general discussion chapter 8, the advantages and limitations of our 
novel in vitro methodology are discussed. Even though the results from the in vitro 
model are inline with the clinical findings, the importance of validating this in vitro 
model with animal experiments are highlighted under future research. In vitro 
methodologies based on two infection models as suggested in this thesis will allow 
better evaluation of biomaterials and coatings prior to animal experiments or human 















































Biomateriaal-geassocieerde infecties (BAI) zijn de belangrijkste oorzaak voor het 
falen van implantaten en kunnen vele jaren na implantatie pas evident worden. 
Biomateriaal-geassocieerde infecties kunnen zich ontwikkelen na contaminatie van 
een implantaat met een micro-organisme tijdens de implantatie (peri-operatief), direct 
na een operatie tijdens de ziekenhuisopname, of veel later doordat micro-organismen 
vanuit wondjes elders in het lichaam zich verspreiden via de bloedbaan. Micro-
organismen in biomateriaal-geassocieerde infecties groeien in een biofilm waardoor 
ze nagenoeg ongevoelig zijn voor antibiotica. In de meeste gevallen moet zo’n 
implantaat worden verwijderd. 
In 1987 introduceerde de orthopeed Anthony G. Gristina de term “Race for the 
surface” om de ontwikkeling van een biomateriaal-geassocieerde infecties te 
beschrijven op een geïmplanteerd biomateriaal. De uitkomst van de ‘race’ tussen 
microbiële adhesie en groei èn integratie van het biomateriaal in het weefsel is een 
belangrijke indicator voor een succesvolle implantatie. Als de ‘race’ wordt gewonnen 
door weefselintegratie, dan wordt het oppervlak bedekt met cellen en weefsel en is 
daardoor minder aantrekkelijk voor bacteriën. Als daarentegen de ‘race’ wordt 
gewonnen door micro-organismen, dan wordt het oppervlak snel bedekt met een 
biofilm, die toxines produceert, waardoor het functioneren van het weefsel sterk 
negatief beïnvloed wordt. Het concept van de ‘Race for the surface” wordt algemeen 
aanvaard in dit onderzoeksveld, maar tot voor kort was er geen methode beschikbaar 
om deze ‘race’ in het laboratorium te bestuderen. 
 Hoofdstuk 1 geeft een overzicht van de belangrijkste oorzaken voor het 
ontwikkelen van biomateriaal-geassocieerde infecties en daarmee het falen van 
implantaten. Onafhankelijk van de manier waarop zo’n infectie is ontstaan hangt het 
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op heden werd de uitkomst van de ‘race’ voorspeld door onderzoekers door in het 
laboratorium te meten in hoeverre biomateriaal oppervlakken of coatings bestand 
waren tegen microbiële adhesie en groei van een biofilm. In een tweede experiment 
werd dan nagegaan of cellen uit weefsels konden hechten aan de oppervlakken en er 
op konden groeien. De invloed van de aanwezigheid van micro-organismen op de 
hechting van weefselcellen en hun groei bleef echter onbekend. Het belangrijkste doel 
van de experimenten beschreven in dit proefschrift is het ontwikkelen van een 
laboratorium techniek die een brug kan vormen tussen in vitro en in vivo studies van 
biomateriaal-geassocieerde infecties. 
 In hoofdstuk 2 wordt als een eerste stap een laboratorium model beschreven 
waarmee Anthony G. Gristina’s ‘Race for the surface’ kan worden bestudeerd. Als 
basis voor de methode diende een peri-operatief model van besmetting, waarbij het 
implantaat voor implantatie wordt besmet met een relatief lage dosis bacteriën. Na 
ontwikkeling van een geschikt groeimedium voor zowel bacteriën als weefselcellen in 
een parallelle plaat doorstroom kamer (‘flow chamber’) , werd de gelijktijdige groei 
van Stafylococcus epidermidis ATCC 35983 en U2OS osteosarcoma cellen gedurende 
48 uur bestudeerd. De uitkomst van de competitie tussen S. epiderimidis en U2OS 
cellen bleek afhankelijk van het aantal bacteriën dat aanwezig was voordat de U2OS 
cellen werden gezaaid en van de aanwezigheid van stroming. Zonder stroming van het 
medium verloren de U2OS cellen de competitie, vermoedelijk door een opeenhoping 
van bacteriële toxines. Bij stroming van het medium bleken de U2OS cellen in staat te 
hechten en te groeien. De continue verversing van medium zorgde waarschijnlijk voor 
verwijdering van de meeste endotoxines van het oppervlak. 
 Dezelfde methode, gebaseerd op het peri-operatieve model van besmetting, 





uitkomst van de competitie tussen S. epidermidis ATCC 35983 en U2OS cellen te 
bepalen. Materialen met oppervlakken verschillend in hydrofobiciteit of bekleed met 
polymeer borsteltjes werden getest (Hoofdstuk 3). Deze studie toonde aan dat in de 
aanwezigheid van S. epidermidis de groei van U2OS cellen werd beperkt op alle 
oppervlakken, maar dat de spreiding van de cellen niet werd beïnvloed. De bekleding 
van het oppervlak met hydrofiele polymeer borsteltjes voorkwam hechting en groei 
van bacteriën en U2OS cellen bijna volledig. Deze studie geeft eens te meer aan dat er 
geen oppervlak is waarop de ‘Race for the surface’ kan worden gewonnen door 
weefselcellen en benadrukt de noodzaak van het ontwikkelen van bio-functionele 
oppervlakken, die biofilmgroei ontmoedigen en weefselcelgroei bevorderen. 
 Bij biomateriaal-geassocieerde infecties kunnen verschillende pathogenen 
betrokken zijn, zoals S. epidermidis, S. aureus, Escherichia coli, Pseudomonas 
aeruginosa, etc. Het is bekend dat de bacteriële virulentie een rol speelt in de mate 
waarin de infectie actief is. In hoofdstuk 4 wordt een studie beschreven waarin de 
invloed van verschillende bacteriestammen van S. epidermidis, S. aureus en P. 
aeruginosa werd gemeten op de groei en spreiding van U2OS cellen in het model, 
zoals beschreven in hoofdstuk 2. U2OS cellen bleken in staat te hechten, spreiden en 
groeien  in de aanwezigheid van hechtende S. epidermidis, maar niet in de 
aanwezigheid van hechtende S. aureus of P. aeruginosa, die alle resulteerden in dood 
van de U2OS cellen binnen 18 uur ondanks stroming van het medium. Deze 
uitkomsten komen overeen met klinische waarnemingen dat biomateriaal-
geassocieerde infecties met S. aureus of P. aeruginosa veel agressiever verlopen dan 
infecties met S. epidermidis. Deze studie geeft het belang van het ontwikkelde model 
aan voor het bestuderen van de effecten van pathogeniciteit van infecterende micro-
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 In de studie beschreven in hoofdstuk 5 werden bekledingen van titanium oxide 
oppervlakken met poly(ethylene glycol) (PEG) borsteltjes al dan niet voorzien van het 
integrine-bindende peptide RGD (arginine-glycine-aspartine zuur) (PEG-RGD) 
vergeleken in het in hoofdstuk 2 beschreven model. In deze studie kregen S. 
epidermidis ATCC 35983 gedurende 2 uur de tijd te hechten aan een oppervlak, 
waarna de weefselcellen werden gezaaid. De gelijktijdige groei van bacteriën en 
weefselcellen werd gedurende 48 uur gevolgd. Na 2 uur bleek de bacteriële hechting 
op de PEG- en PEG-RGD beklede oppervlakken 20-voudig gereduceerd te zijn ten 
opzichte van kaal titanium oxide. Na 48 uur waren op alle drie de oppervlakken 
biofilms te zien. De biofilms op PEG- en PEG-RGD beklede oppervlakken bleken los 
te laten bij hogere stroming snelheden. Onafhankelijk van de aanwezigheid van een 
biofilm bleken U2OS cellen niet op PEG beklede oppervlakken te hechten, laat staan 
te groeien. Op de ‘bioactieve’ PEG-RGD bekleding daarentegen, bleken de U2OS 
cellen goed te hechten en te spreiden ook in aanwezigheid van een biofilm. De 
bedekking van het oppervlak met U2OS cellen was significant hoger vergeleken met 
kaal titanium oxide. Met deze studie wordt aangetoond dat een ‘bioactieve’ coating 
waardevol kan zijn om het risico van een infectie terug te dringen. 
 In het door Anthony G. Gristina beschreven concept van de ‘Race for de 
surface’ is de integratie van het materiaal in het weefsel een belangrijke 
beschermende factor tegen microbiële besmetting van het oppervlak. Daarom was de 
studie beschreven in hoofdstuk 6 gericht op de ontwikkeling van een post-operatief 
bacteriële contaminatie model van het oppervlak van een implantaat. De invloed van 
de mate van bedekking van het oppervlak met weefselcellen op de balans tussen 
weefselcelgroei en S. epidermidis biofilm vorming werd bestudeerd. In deze studie 





spreiden gedurende 24 uur. Daarna werd een vast aantal S. epidermidis gezaaid en 
werd de gelijktijdige groei van bacteriën en weefselcellen gevolgd in de tijd onder 
vloeistofstroming (0.14 s-1). Weefselcelgroei werd ernstig geremd als bacteriën 
werden gezaaid op oppervlakken met lage aantallen weefselcellen (2.5 x 104 cellen 
cm-2), maar bij hogere weefselceldichtheden (8.2 x 104 en 17 x 104 cellen cm-2) 
hadden de aanwezige S. epidermidis geen effect op de celgroei. Een kritische 
weefselceldichtheid werd bepaald: 8.2 x 104 cellen cm-2, waarboven aanwezige S. 
epidermidis niet langer een negatief effect op de weefselcelgroei hadden. Deze studie 
toont aan dat bij een zekere mate van bedekking van een biomateriaal oppervlak met 
gastheercellen het implantaat effectief beschermd lijkt tegen besmetting door S. 
epidermidis. 
 Het succes van een implantaat is een complex samenspel van factoren, zoals 
de fysisch-chemische eigenschappen van het oppervlak, bacteriële virulentie en de 
effectiviteit van het immuunsysteem. Als een tweede stap in het overbruggen van de 
kloof tussen in vitro en in vivo studies, werd de invloed van immuuncellen 
(macrofagen) op de competitie tussen bacteriën en weefselcellen bepaald. Deze 
studie, beschreven in hoofdstuk 7, gebaseerd op het peri-operatieve contaminatie 
model (hoofdstuk 2), valideert de interacties tussen meerdere celtypes (bacteriën, 
macrofagen, en osteosarcomacellen) en benadert meer de in vivo situatie dan wanneer 
slechts één celtype wordt gebruikt. De resultaten tonen aan dat ondanks de 
aanwezigheid van macrofagen de weefselcellen de ‘Race for the surface’ verliezen in 
de aanwezigheid van ‘hoog’ virulente S. aureus, gelijk de in vivo situatie 
 In de algemene discussie, hoofdstuk 8, worden de voordelen en beperkingen 
van onze nieuwe in vitro methodiek besproken. Hoewel de resultaten van de studies 




   
 
141
van validatie van de methode door middel van proefdierexperimenten benadrukt. De 
beide in vitro modellen (peri-operatieve en post-operatieve contaminatie) beschreven 
in dit proefschrift zullen leiden tot een betere evaluatie van biomaterialen en coatings, 
voordat overgegaan wordt naar dierstudies of klinische experimenten en daarmee 
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